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CHAPTER I 
 
GENERAL INTRODUCTION 
 
One question that has attracted the interest of scientists for decades is how 
the vascular system of the lung is formed and maintained. To generate a 
structurally and functionally complex system with enough surface area and 
circulation for gas exchange, cells of the lung endothelium must undergo 
extensive temporally and spatially regulated developmental processes involving 
proliferation, differentiation and migration (Chuang and McMahon, 2003; Price 
and Stiles, 1996; Warburton et al., 1998) Furthermore, the adult lung is constantly 
under challenges of injury caused by environmental or intrinsic factors. In order to 
protect the endothelial barrier from extensive damage and maintain proper lung 
functions, the endothelial cells possess a highly sophisticated protective 
machinery and self-renewal abilities (Orfanos et al., 2004; Ryan, 1986). In the 
past few years, several key factors that mediate these processes have been 
identified and it is becoming clear that they are well-coordinated by cross-talk 
between endothelial and epithelial cells (Blume et al., 1998; Calabrese et al., 
2005; Hermanns et al., 2004; Jakkula et al., 2000; Maeda et al., 2002; Parera et 
al., 2005; Wendt et al., 1994). However the precise molecular profile of lung 
organogenesis still remains to be established. This introduction reviews the 
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general processes of lung angiogenesis and summarizes what is known about 
endothelial damage and repair, as well as discusses the possibility that inhibitor of 
differentiation-1 (Id1) may be a key factor that mediates these processes. 
 
Part I  Development of the Pulmonary Vasculature 
 
Most of our current understanding of mammalian lung development comes 
from studies using mouse models. In the mouse, the lung first originates from the 
laryngotracheal groove at embryonic day 9-9.5, and then divides laterally into two 
primordial lung buds, which invade the surrounding splanchnic mesenchyme. 
Starting at around E10.5, a sequence of highly ordered patterning events termed 
branching morphogenesis occur in the epithelium, generating the bronchial tree 
and the proximal-distal axis of the lung (Cardoso, 2006). Together with the 
formation of the bronchial tree, its surrounding mesenchyme differentiates into 
airway smooth muscle (ASM), which is juxtaposed around the tubules, and also 
gives rise to the vasculature and neural networks (Tollet et al., 2001). The 
formation of the vascular system begins as early as E9.0, when intercellular 
spaces are apparent in the lung mesenchyme. Yet precisely how the vasculature 
develops is not clear. There are three distinct lung vascular morphogenesis 
models (Fig1.1) (Parera et al., 2005). The first model (vasculogenesis & 
angiogenesis) proposes that lung mesenchymal cells firstly regroup to generate 
2
Fig 1.1 Proposed models for embryonic lung 
endothelial morphogenesis.  
Reprinted from Parera et al. Am J Physiol Lung Cell 
Mol Physiol 2005 
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endothelial cells. Then sprouting of new vessels from the central pulmonary 
vascular trunks to the peripheral lung mesenchyme occurs and connections 
between peripheral and central vascular systems take place later on (deMello et 
al., 1997). The second model (vasculogenesis) proposes that distal 
vasculogenesis alone is the main mechanism that forms the lung vasculature 
(Hall et al., 2000). The third model, which is favored by more researchers than the 
others, claims that distal angiogenesis (formation and sprouting of new capillaries 
from pre-existing vessels accompanied by lung bud growth) is a major player in 
embryonic lung vascular development (Parera et al., 2005).  Regardless of the 
differences between these proposed models, it is agreed that angioblast 
aggregation, endothelial differentiation and migration as well as formation of 
capillary plexus are the primary processes that take place during lung endothelial 
morphogenesis.  
       Defects in the developmental processes of embryonic lung endothelial 
morphogenesis may contribute to a variety of neonatal pulmonary disorders 
involving circulation problems.  One particular type of human disease that 
attracted growing attention in recent years is called Bronchopulmonary Dysplasia 
(BPD). BPD is a chronic lung disease of infancy characterized by arrested lung 
growth with impaired vascular and alveolar development, which results in 
persistent respiratory problems (Stenmark and Abman, 2005). The 
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underdeveloped vessels in lungs of BPD patients often appear dilated and the 
microvascular structure disorganized. It is believed that disrupted vascular growth 
plays a key role in the pathogenesis of BPD (Lang et al., 2004; Stenmark and 
Balasubramaniam, 2005). However, detailed knowledge about the molecular 
mechanisms controlling prenatal vascular development is still needed to 
understand how BPD develops and to generate effective therapeutic modalities. 
Other examples of development-related pulmonary vascular diseases include 
pulmonary arteriovenous malformations (PAVMs), persistent pulmonary 
hypertension of the newborn (PPHN) and congenital diaphragmatic hernia (CDH) 
(Lang et al., 2004). Development of future therapies will rely primarily on the 
discovery of new cellular and molecular machineries responsible for the 
pathogenesis of these diseases. 
Extensive studies have been done on the branching and differentiation of 
the respiratory epithelium, but relatively little is known about the mechanism 
underlying the regulation of lung mesenchyme development, particularly vascular 
development. It has been proposed that Notch signaling regulates multiple 
aspects of vascular morphogenesis through its primary effectors, the HERP family 
of bHLH proteins (Iso et al., 2003b). Other growth factors, such as the VEGF 
family (Gebb and Shannon, 2000; Healy et al., 2000), angiopoietin family 
(Koblizek et al., 1998; Maisonpierre et al., 1997) and ephrin family (Hall et al., 
2002) are also involved in pulmonary vascular development. The detailed 
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mechanisms remain poorly understood and many issues wait to be addressed. 
Thus identification of novel key regulators controlling mesenchymal development 
of the lung is crucial to gain insight into the cellular processes governing 
pulmonary vascular development.  
 
Part II  Acute Lung Injury and Pulmonary Fibrosis 
 
Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) 
The terms Acute Lung Injury (ALI) and its more severe form, Acute 
Respiratory Distress Syndrome (ARDS), refer to a spectrum of increasingly 
severe syndromes of lung injury. This disease is characterized by widespread 
alveolar epithelial and capillary endothelial cell damage that occurs rapidly after 
external or internal insults, causing dyspnea, severe hypoxemia, decreased lung 
compliance and pulmonary edema (Matthay and Zimmerman, 2005; Matthay et 
al., 2003). ALI/ARDS have been diagnosed in adults as well as children, and often 
lead to acute respiratory failure with high mortality (30-40%) in critically ill patients. 
It is estimated that as much as 36,000 deaths per year in the U.S. are contributed 
by ARDS (Hudson and Steinberg, 1999). Currently the only effective treatment 
available for acute respiratory failure caused by ALI is mechanical ventilation 
(Matthay and Zimmerman, 2005). Considerable work is still needed to provide 
additional therapeutic approaches.  
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The insults leading to ALI can be either directly targeted to the lung, such 
as lung infection or aspiration, or indirectly by sepsis, trauma or large volume 
blood replacement and other systemic problems. The most common feature of 
ALI at early phase is pulmonary edema, largely due to increase in lung vascular 
permeability. Systemic conditions can injure cells of the pulmonary endothelial 
barrier more rapidly than other cell types in the lung, which makes the 
endothelium the initial mediator in permeability changes associated with ALI 
(Groeneveld, 2002) caused by sepsis or trauma. Epithelial damages, together 
with inflammatory responses are also major contributors of ALI pathogenesis 
(Abraham, 2003; Goodman et al., 2003). 
Rodent have become the most widely used animal models in ALI research 
in recent years. Currently available models enable investigators to choose 
between cell-type specific and systemic approaches. Intratracheal administration 
of lipopolysaccharide (LPS) in mice triggers local infection that targets pulmonary 
epithelial cells (Thorn, 2001). Intravenous injection of bleomycin induces 
endothelial cell death directly, which leads to altered pulmonary vascular 
permeability (Azuma et al., 2000). Other more complex models include cecal 
ligation and puncture (CLP), which causes systemic sepsis in mice and ALI 
indirectly due to poly-microbial infection (Ebong et al., 1999; Guo et al., 2002; 
Laudes et al., 2004). The availability of mouse knockout and transgenic strains 
provides a great advantage to the study of the important roles of specific genes 
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and pathways involved in ALI. Tumor Necrosis Factor (TNF) alpha and interleukin 
(IL) signaling are two major players during the initial phase of ALI, mainly 
functioning by mediating and amplifying inflammatory responses in the lung 
epithelium and endothelium (Folkesson et al., 1995; Goldblum et al., 1989; Ortiz 
et al., 1998; Smith et al., 1998). It is believed that the key transcriptional factor 
involved in ALI pathogenesis is NF-κΒ, which induces the transcription of many 
injury-response genes such as cytokines, growth factors or adhesion molecules. 
And the transcriptional control of NF-κΒ is well coordinated through interaction 
with other transcription factors (Fan et al., 2001). 
 
Idiopathic Pulmonary Fibrosis (IPF)  
Idiopathic interstitial pneumonias consist of a group of six different types of 
devastating lung diseases of which idiopathic pulmonary fibrosis (IPF) is the most 
common type (Garantziotis et al., 2004). IPF is a progressive lung disease of 
unknown etiology with poor prognosis and no effective treatment. It is often 
diagnosed in individuals between 50 to 70 years of age, manifested as shortness 
of breath due to impaired gas exchange. The estimated annual incidence is 10 
cases per 100,000 (Selman et al., 2001) although the true prevalence can vary 
depending on the population studied (Hodgson et al., 2002; Johnston et al., 1997). 
IPF is characterized by accumulation of inflammatory cells, epithelial and 
endothelial apoptosis, fibroblast proliferation and an abundance of myofibroblasts 
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in the lung interstitium, increased deposition of extracellular matrix proteins 
resulting in substantial loss of intact respiratory alveoli and irreversible distortion 
of the lung architecture (Kuhn et al., 1989; Phan, 2002; Phan, 2003; Selman et al., 
2001; Tomasek et al., 2002; Zhang et al., 1994).  
The disease is thought to result from persistent or recurrent episodes of 
lung injury triggering a pathophysiological response (Gross and Hunninghake, 
2001; Katzenstein and Myers, 1998; Mason et al., 1999; White et al., 2003). IPF 
has been associated with identified mutations in the gene for surfactant protein C 
(Lawson et al., 2004), however, it is believed that adverse environmental 
conditions play a role in sporadic cases (Garantziotis et al., 2004; Green, 2002). 
Environmental factors can generate oxidant stress that has adverse effects in the 
lung (Gillissen and Nowak, 1998; Kim et al., 2000; Kinnula et al., 2005; Quinlan et 
al., 1994). IPF patients have higher levels of oxidant stress with elevated reactive 
free oxygen radical levels, reduced antioxidant defense and increased lipid 
peroxidation than control patients (Beeh et al., 2002; Gillissen and Nowak, 1998; 
Jack et al., 1996; Kinnula et al., 2005; Kurup and Kurup, 2003; Lenz et al., 1996; 
Rahman and Kelly, 2003; Rahman et al., 1999; Schunemann et al., 1997). 
Significant deficiency of the cellular antioxidant, reduced glutathione, has been 
reported in the lower respiratory tracts of IPF patients confirming the established 
role of oxidant/antioxidant imbalance as a major cause of cell damage in the 
pathogenesis of IPF (Beeh et al., 2002; Rahman and MacNee, 2000). Antioxidant 
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defense therapy has been suggested for lung diseases involving high alveolar 
oxidant burden such as IPF (Buhl et al., 1996; Gillissen and Nowak, 1998; Kinnula 
et al., 2005; Meyer et al., 1995). 
Bleomycin is used clinically as a chemotherapeutic cancer drug (Fig1.2-A). 
However, it often causes detrimental toxic side effects including lung fibrosis (Hay 
et al., 1991). Intratracheal instillation of bleomycin is routinely used to induce 
pulmonary fibrosis in animal models. Mice treated with bleomycin generally 
develop fibrotic foci from the second week after injection (Fig1.2-B). The effect of 
bleomycin is, in part, mediated by TGF-β signaling, consistent with the 
established involvement of this important fibrogenic cytokine in wound healing by 
promoting myofibroblast differentiation, survival and persistence (Breen et al., 
1992; Cutroneo and Phan, 2003; Desmouliere et al., 1993; Izbicki et al., 2002; 
Lawson et al., 2005b; Nakao et al., 1999; Phan and Kunkel, 1992; Zhang et al., 
1996; Zhang et al., 1995). Alveolar epithelial cells in IPF are known to secrete, 
among other factors, cytokines such as TGF-β and TNF-α, which have been 
shown to promote fibroblast activation (Kapanci et al., 1995; Khalil et al., 1991; 
Miyazaki et al., 1995). In bleomycin-induced lung fibrosis, it is believed that early 
inflammation occurs in response to epithelial injury (Adamson and Bakowska, 
1999; Deterding et al., 1997; Guo et al., 1998; Sugahara et al., 1998; Yi et al., 
1996). Release of chemoattractants by injured epithelial cells can promote 
recruitment of inflammatory cells, which adhere to and migrate across the lung 
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Fig 1.2 Intratracheal bleomycin induced mouse lung 
injury model A. Chemical structure of bleomycin molecule 
and mechanism of bleomycin induced cell apoptosis.  
Adapted form B. Time frame for acute (0-1 week) and 
chronic (2-6 week) phases of lung injury triggered by 
intratracheal administration of bleomycin.  
11
endothelium into the airways (Liu et al., 1996). Epithelial injury and defects in 
re-epithelialization may lead to disruption of normal epithelial-fibroblast 
interactions, hence promoting the fibrotic process (Adamson et al., 1988; 
Chapman, 2004; Kasper and Haroske, 1996; Pardo and Selman, 2002a; Pardo 
and Selman, 2002b; Selman et al., 2001; Selman et al., 2004; Thannickal et al., 
2004; White et al., 2003). Contributions by circulating fibroblasts as well as 
extracellular matrix (ECM) to the pathologic mechanisms have also been brought 
into consideration (Pardo and Selman, 2002a; Selman et al., 2001). 
 
Pulmonary endothelium and response to injury 
The adult lung microvascular endothelial structure originates from 
embryonic mesenchyme that gradually develops into a highly sophisticated 
vascular network system along with epithelial development. Besides providing a 
blood barrier and an interface for gas exchange, the endothelial cells also 
possess other important functional properties such as the secretion of enzymes 
and growth factors or participation in immune responses (Reviewed in Orfanos et 
al., 2004). Since the pulmonary endothelium is a major component of the adult 
lung structure and its integrity is crucial for maintaining lung homeostasis, its 
critical role in the pathogenesis of ALI is well recognized (Block, 1992; Orfanos et 
al., 2004; Wenzel et al., 2002). Insults affecting endothelial cell survival and 
functions often directly result in breakdown of the permeability balance, which is 
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an early pathological feature of acute lung injury. The pulmonary endothelium is 
not only a major target of insults, but also serves as a transmitter and amplifier of 
the damaging effects. Upon activation of endothelial cells by initial injury-induced 
signaling pathways, endothelial cells express E-selectin and ICAM-1, molecules 
that are essentially required for neutrophil recruitment, adhesion, transmigration 
and subsequent inflammatory responses (Albelda et al., 1994). On the other hand, 
activated endothelial cells also produce hemostatic modulators such as von 
Willibrand Factor (vWF) (Ware et al., 2001; Ware et al., 2004), thrombomodulin 
(TM) (Kawanami et al., 2000; MacGregor et al., 1997) and plasminogen activator 
inhibitors (PAI) (Wenzel et al., 2002). Release of these molecules contributes 
significantly to the decrease of hemofluidity in the circulation system of ALI 
patients. The role of pulmonary endothelial cells to mediate injury response is 
delicately counterbalanced by the protective and repair machineries they possess. 
Angiotensin-converting enzyme (ACE), for instance, is an ectoenzyme produced 
by endothelial cells that maintains endothelial barrier homeostasis. Reduction of 
ACE activity is one of the earliest signs of ALI and the protective role of ACE-2 
against ALI has been established through examination of ACE-2 knockout mice 
(Imai et al., 2005; Lazo et al., 1986; Newman et al., 1980). Plasminogen activators 
(PA) are also synthesized and released by pulmonary endothelial cells. They 
serve as inducers of endothelial fibrinolytic activities that are required during 
repair and restoration processes (Block, 1992; Idell, 2003).  
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While recent focus has been on the role of epithelial dysfunction in IPF 
(Chapman, 2004; Pardo and Selman, 2002a; Selman et al., 2001; Thannickal et 
al., 2004; White et al., 2003), much less is known about the specific roles of the 
endothelium which is also a target tissue in lung injury. It has been suggested that 
aberrant vascular remodeling, resulting in net increase in angiogenesis, likely 
plays an indispensable role in the development and progression of lung fibrosis 
(Burdick et al., 2005; Keane et al., 1999; Keane et al., 2001). To date, the extent 
of neovacularization and its role in the pathogenesis of IPF remains contradictory 
and unresolved. Recent studies indicate elevated serum levels of endostatin, an 
anti-angiogenic factor, in IPF patients suggesting a correlation between endostatin 
and lung fibrosis (Sumi et al., 2005). Vascular heterogeneity and remodeling was 
found in patients with IPF (Ebina et al., 2004; Renzoni et al., 2003) and it has 
been suggested that functional defects of the lung microvessels may play a role in 
the pathogenesis of lung fibrosis (Koyama et al., 2002; Renzoni et al., 2003).  
The level of vascular endothelial growth factor (VEGF), an angiogenic factor, was 
significantly depressed (Meyer et al., 2000) while pigment epithelium-derived 
factor (PDGF), an angiostatic factor, was increased in IPF patients (Cosgrove et 
al., 2004). However, it remains unclear as to how vascular remodeling 
mechanistically contributes to lung fibrosis. Importantly, host responses to lung 
injury involving molecular cytoprotective mechanisms of the lung endothelium 
remain to be elucidated. 
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Part III  The Inhibitor of Differentiation family proteins 
 
Id proteins as transcriptional repressors  
The first member of the Id family of proteins was discovered in 1990, in a 
screen for cDNAs encoding novel helix-loop-helix (HLH) proteins in murine 
erythroleukemia cells (Benezra et al., 1990). The Id family is a distinct subfamily 
of HLH proteins that lack a DNA-binding region and function by dimerizing with 
other transcriptional regulators, primarily basic-HLH (bHLH) factors (Fig1.3-A). 
Basic-HLH transcription factors are well-known cell differentiation stimulators (Lee, 
1997; Massari and Murre, 2000; Olson and Klein, 1994). In general, 
tissue-specific bHLH factors form dimers with ubiquitously expressed bHLH 
factors, bind to DNA and trigger tissue-specific gene expression that promotes 
cell differentiation. However, once bHLH proteins interact with Id proteins via their 
HLH domain, they are no longer able to bind to DNA or form functional 
heterodimers with other bHLH partners. Thus, Id proteins negatively regulate 
bHLH factors, leading to the inhibition of differentiation (Fig1.4) (Norton, 2000). In 
addition to bHLH factors, several other families and types of non-bHLH proteins 
also interact with and are functionally antagonized by Id proteins such as the 
ETS-domain transcription factors. Id proteins physically interact with the TCF 
subfamily of ETS proteins to inhibit their DNA binding and ability to induce 
immediate early genes (Yates et al., 1999). Other identified Id interacting partners 
15
Fig 1.3 The inhibitor of DNA binding/differentiation 
family proteins.  A. Biochemical structure of Helix-Loop-Helix 
(HLH) domain in Id family proteins and the conformation of the 
dimerization. Adapted from Wibley et al. Biochimica 
Biophysical Acta 1996 B. Mammalian Id proteins and their 
conserved HLH domain sequences.
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include paired-domain homeobox (PAX) transcriptional factors (Roberts et al., 
2001), Z-DNA-binding protein (Shoji et al., 1995) as well as the pRB tumor 
suppressor and related “pocket” proteins (Iavarone et al., 1994). A summary of 
identified interaction partners of Id proteins is outlined in Table 1.1.  
Id proteins are highly conserved throughout evolution. Genes encoding 
Id-like proteins have been cloned in organisms such as Drosophila (Ellis et al., 
1990; Garrell and Modolell, 1990), Xenopus (Wilson and Mohun, 1995), Zebrafish 
(Sawai and Campos-Ortega, 1997), mouse and human (Ellmeier et al., 1992). In 
Drosophila, a single locus termed extramicrochaetae (EMC), encodes an HLH 
protein showing high degree of structural and functional similarity to the murine Id 
proteins (Campuzano, 2001). EMC is apparently required for normal development, 
as EMC deficient flies die during embryogenesis. Studies on various partial loss- 
and gain-of-function mutants revealed that EMC is required for multiple processes 
in Drosophila development such as wing morphogenesis, neurogenesis and sex 
determination. In the Drosophila trachea, a functional counterpart of the 
mammalian lung, EMC is expressed in cells surrounding and including the 
invaginating tracheal pits. Interestingly, in EMC mutants, tracheal development is 
often affected; exhibiting structural alterations of the tracheal tree, similar to the 
phenotypes found in mutants for Notch and Breathless (Cubas et al., 1994). 
These studies may provide a paradigm for understanding how Id proteins function 
in mammalian lung development.  
17
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Fig 1.4 Schematical representation of the molecular 
mechanism of Id proteins’ role as transcription inhibitor.  
Id proteins are produced in the cytoplasm and translocated 
into the nucleus upon binding to bHLH factors. The 
interaction between Id proteins and bHLH factors disrupted 
the formation of functional dimers of bHLH proteins that can 
recognize and bind to E-box DNA sequence. The subsequent 
gene activation is then inhibited.
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Currently, four Id family members have been identified in mammals 
(Fig1.3-B). The sequences within the HLH domains are highly conserved among 
mammalian Id family members (Fig1.3-B), whereas the sequences outside the 
HLH domain display extensive divergence (Norton et al., 1998). The Id genes 
exhibit widespread and overlapping expression patterns in multiple tissues during 
mouse development. In general, Id1, Id2 and Id3 are readily detected in organs 
undergoing active morphogenetic activities, such as gut, lung, kidney, tooth and 
some glandular structures, whereas Id4 expression is only restricted to neuronal 
tissues and stomach. In organs that arise from mesoderm-endoderm interactions, 
Id1 and Id3 are usually expressed in mesenchymal cells surrounding the 
endodermal epithelium, while Id2 is located in the epithelium. In particular, strong 
Id1 and Id3 signals can be detected in the mesenchyme of the mouse lung, 
suggesting their importance in lung morphogenesis (Evans and O'Brien, 1993; 
Jen et al., 1996; Jen et al., 1997; Zhu et al., 1995).   
Id proteins have distinct functions in development and disease, playing 
important roles in regulating proliferation and differentiation of various cell types 
including epithelial, endothelial, fibroblast and neural precursor cells (Benezra et 
al., 2001; Engel and Murre, 2001; Fong et al., 2003; Jen et al., 1997; Li et al., 
2005; Lyden et al., 2001; Lyden et al., 1999; Ruzinova and Benezra, 2003; Sikder 
et al., 2003). One characteristic function of Id proteins is their ability to inhibit 
Smooth muscle alpha-actin-positive myofibroblast differentiation by disrupting 
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transcription complex formation between bHLH protein E2A and MyoD (Sun et al., 
1991). Another important role of Id proteins is their active engagement in cell cycle 
regulation as well as promoting cell survival and delaying onset of cellular 
senescence (Zebedee and Hara, 2001). Id proteins positively regulate cell 
proliferation mainly through repressing the expression of CDK inhibitors such as 
p15, p16 and p21 (Yokota and Mori, 2002; Zebedee and Hara, 2001). Ids exert 
these functions by directly binding to and disrupting transcriptional dimers formed 
by either bHLH proteins or ETS family proteins.  
As in Drosophila, Id genes are essential for mouse development, although 
functional redundancy exists among the four Id members. Among Id 
single-knockout mice, only Id2-/- mice displayed obvious abnormalities such as 
retarded growth and neonatal morbidity (Yokota et al., 1999). However, all 
combinations of double knockouts of Id1, Id2 and Id3 are embryonic lethal 
(Fraidenraich et al., 2004; Norton et al., 1998). In addition, severe defects in 
neurogenesis and angiogenesis were observed in the brain when Id1 and Id3, the 
two Id members showing extensive overlapping expression patterns during 
development, were inactivated simultaneously (Lyden et al., 1999).  Id1-/-Id3-/- 
mice die at E13.5 due to intraventricular hemorrhage. Starting from E11.5, 
neuroblasts are prematurely withdrawn from the cell cycle in the mutant, 
accompanied by increased expression of CDK inhibitors and neural-specific 
differentiation markers. Id1-/-Id3-/- mice also exhibited vascular malformations in 
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the forebrain and absence of branching and sprouting of blood vessels into the 
neuroectoderm. Consistently, the expression of VEGF, Flk-1 and Smooth muscle 
α-actin were reduced within the malformed vascular structures (Lyden et al., 
1999). The apparent defects in proliferation and differentiation of the Id1-/-Id3-/- 
brain underscore the critical role of these genes in the endothelium as only Id1 
and Id3 are detected in endothelial cells of the brain (Jen et al., 1996). A similar 
situation can be found in the lung mesenchyme, where only Id1 and Id3 are 
expressed (Jen et al., 1996), suggesting a potential role for these Id proteins in 
neurogenesis, myogenesis and vascular development, all of which occur in the 
lung mesenchyme.  
 
The roles of Id proteins in vascular development and maintenance 
Id proteins are prominently expressed in endothelial cells throughout 
development and in some adult organs. Id1, Id2 and Id3 are all expressed in 
blood vessels in most parts of the mouse embryo except for the embryonic brain 
where only Id1 and Id3 are expressed (Jen et al., 1997; Lyden et al., 1999). 
Although Id gene expression is normally downregulated or turned off in most adult 
organs, they are frequently upregulated exclusively in endothelial cells in most 
tumor tissues (Perk et al., 2006). Upregulation of Id1 expression in endothelial 
cells is also detected during hypoxic vascular remodeling in pulmonary 
hypertension, suggesting a contributory role of Id1 in maintaining endothelial 
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homeostasis (Frank et al., 2005). 
Increasing evidence suggests that Id proteins function as key players in 
endothelial function and homeostasis (Benezra et al., 2001). Mice lacking Id1 and 
Id3 functions display brain hemorrhage during development and defects in 
tumor-promoted angiogenesis (Lyden et al., 1999). Deregulated Id1 expression in 
endothelial cells substantially affects angiogenesis and tumor growth in various 
tumor models (de Candia et al., 2004; Iavarone and Lasorella, 2004; Li et al., 
2004a; Ling et al., 2005). In vitro studies demonstrated that overexpression of Id 
genes reduces human endothelial cell apoptosis rate (Nishiyama et al., 2005) 
(Valdimarsdottir et al., 2002) although the underlying molecular mechanisms 
governing this process remain unknown. Id1 has also been shown to delay 
endothelial senescence by suppressing the expression of CDK inhibitors p16 and 
p21. Thus Id function may be an important component of the cellular stress 
response pathway (Alani et al., 2001; Sharpless et al., 2001; Tang et al., 2002). 
Forced expression of Id1 in Human Umbilical Vein Endothelial Cells (HUVECs) 
promotes angiogenic properties such as migration and tube formation (Nishiyama 
et al., 2005; Sakurai et al., 2004; Valdimarsdottir et al., 2002). Transplantation of 
Id1-overexpressing HUVECs into mice increased capillary density and limb 
salvage rate, indicating involvement of Id1 in endothelial repair (Nishiyama et al., 
2005). 
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It has been proposed that the in vitro angiogenic activity of Id proteins may 
be partly mediated by induction of angiopoietin-1 (Ang-1) transcription, an 
endothelial survival factor that augments endothelial cell migration and reduces 
the rate of apoptosis. However no evidence is yet available to prove that the 
regulation of Ang-1 by Id1 is direct. The function of Id1 in angiogenesis has also 
been associated with its ability to regulate the expression of matrix 
metalloproteinases (MMPs) and integrins. (Benezra et al., 2001; Coppe et al., 
2004; Desprez et al., 1998; Sakurai et al., 2004). The MMPs are a family of Zn2+- 
or Ca2+-dependent endopeptides, which function primarily to degrade 
extracellular matrix. They are actively engaged in capillary formation and 
sprouting during endothelial morphogenesis and compromised MMP activity may 
result in defects in angiogenesis in vivo (Bergers et al., 2000; Hiraoka et al., 1998; 
Hotary et al., 2000; Vu et al., 1998). So far two MMP family genes, MMP-2 and 
MMP-9, are shown to be transcriptionally regulated by Id proteins in different 
contexts. Forced expression of Id1 and Id3 in HUVEC cells induces increase in 
mRNA levels of both MMP-2 and MMP-9 (Sakurai et al., 2004). Knockdown of Id1 
and Id3 by RNAi specifically abolished induction of MMP-2 expression by VEGF, 
but not that of MMP-9 (Sakurai et al., 2004). In addition, tumor endothelial cells 
lacking Id1 function also showed downregulation of MMP-2 expression (Ruzinova 
et al., 2003). Although the detailed transcriptional controlling system is not yet 
established, it remains an interesting subject for future studies. 
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CHAPTER II 
 
 
 
ID1 AND ID3 FUNCTIONS IN EMBRYONIC LUNG VASCULAR DEVELOPMENT 
 
 
 
Introduction 
 
Previous studies have suggested that Id proteins are crucial for vascular 
development both in the mouse forebrain and in tumors (de Candia et al., 2004; 
Iavarone and Lasorella, 2004; Li et al., 2004a; Ling et al., 2005; Lyden et al., 
1999). As mentioned in the introduction, in the E12.5 lung mesenchyme, the 
expression domains of Id1 and Id3 overlap with the region where pecam-1 
positive endothelial cells are generated (Jen et al., 1996), suggesting that these 
Ids may be involved in vascular development. Moreover, in vitro studies using 
cultured endothelial cells from various tissue origins revealed that the Id genes 
could facilitate endothelial cell proliferation, migration and tube formation during 
angiogenesis, indicating the critical influence of Id proteins on vascular 
development (Nishiyama et al., 2005; Sakurai et al., 2004; Valdimarsdottir et al., 
2002). In this chapter, I will mainly address the potential roles of Id1 and Id3 in 
vascular development during embryonic lung mesenchymal cell differentiation 
and the molecular mechanisms contributing to those functions.  
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Experimental Procedures 
 
In situ hybridization 
Cryosection in situ hybridizations were performed as previously described 
(Litingtung et al., 1998). Id1 and Id3 cDNAs generated outside of the conserved 
HLH domain (gift of Dr. Benezra, (Jen et al., 1996)) were used as templates for 
synthesizing digoxygenin-labeled riboprobes.  
 
Immunohistochemistry 
Labeling using antibodies against Pecam/CD31 and MMP-2 were 
performed on 5-µm tissue sections from paraffin-embedded embryos fixed in 4% 
paraformaldehyde for 2 hours at 4°C. Paraffin sections were deparaffinized and 
rehydrated according to standard protocols. Endogenous peroxidase activity was 
blocked using 3% H2O2 in methanol for 10 min at room temperature (RT). To 
reveal Pecam-1 and MMP-2 antigen, sections were antigen-retrieved by trypsin 
digestion using 0.75mg/ml at RT for 5 min. The antibodies used were rat 
anti-CD31 (BD Pharmingen, 1:10 dilution) and mouse anti-MMP2 (Neomarkers, 
1:100 dilution). Alexa 488 (green)- or Alexa 568 (red)-conjugated secondary 
antibodies (Molecular Probes) were applied at 1:600 dilution for 1 h at room 
temperature. 
For whole-mount immunohistochemistry of CD31, cultured embryonic 
lungs were collected and fixed in 4% paraformaldehyde for 2 hours at 4°C. After 
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staining, lungs were immersed in PBS solution before visualization. Confocal 
images were taken using the Zeiss LSM510 confocal microscope at the Vanderbilt 
Cell Imaging Core. Results were presented as screen captures of 3D z-stack 
overlays. 
 
Terminal deoxynucleotidyl transferase–mediated dUTP Nick End Labeling 
(TUNEL) 
For cell death detection in lung tissue sections, paraformaldehyde-fixed 
paraffin sections were treated with trypsin for 5 min and apoptotic cells were 
detected by TUNEL using the In situ Cell Death Detection Kit (Chemicon) 
according to manufacturer’s protocol.  Slides were subsequently double-stained 
with CD31 to mark endothelial cells. 
 
Kidney Capsule 
Kidney capsule implantation of embryonic lungs was performed as 
previously described (Vu et al., 2003). Briefly, adult male C57BL6 mice were 
anesthetized and a dorsal incision was made to expose the kidney on one side. 
Freshly dissected E11.5 lungs were placed underneath the membranous capsule 
through a small opening (1-2mm) using blunt-end glass needles. Two embryonic 
lungs were implanted in each kidney. The kidney was then placed back into 
position and the wound was resealed using surgical suture. Host mice were 
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sacrificed 6 days after surgery and grafted lungs were collected and fixed for 
analysis. 
 
Lung organ culture under hypoxic condition 
The lung culture method used was performed essentially as previously 
described (Li et al., 2004b). Briefly, wildtype or Id1-/-Id3-/- lungs were dissected 
out at E11.5 and cultured on nucleopore polycarbonate filters (8um pore size, 
Millipore) in standard DMEM medium with 10%FBS for 48 h in a hypoxia chamber 
with 3% oxygen before being collected and fixed for staining.  
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Results 
 
Embryonic Id1 and Id3 expression are predominantly in the distal lung 
mesenchyme 
Expression of Id1 and Id3 in the developing lung were reported more than 
a decade ago (Evans and O'Brien, 1993; Jen et al., 1996; Jen et al., 1997; Zhu et 
al., 1995), but detailed examination is lacking. In order to elucidate the role of Id 
proteins during lung mesenchymal development, we started by establishing the 
precise spatial expression patterns of Id1 and Id3 in the embryonic lung 
mesenchyme. The riboprobes for Id1 and Id3 genes were generated outside of 
the conserved HLH domain to ensure specificity (gifts of Dr. Benezra). RNA in situ 
hybridization was performed on E12.5 wildtype lung cryosections. As presented in 
Fig2.1, both Id1 and Id3 mRNA are localized mainly in the distal mesenchyme, 
with little expression in the cell layers immediately adjacent to the proximal 
epithelium (Fig2.1 arrows). Interestingly, when we correlated the expression 
patterns of Id1 and Id3 with that of endothelial marker CD31/Pecam-1 (Fig2.1-B), 
we observed that they have similar expression patterns in the lung. These results 
corroborate well with previous studies, which showed that Id1 and Id3 are 
frequently detected in endothelial cells throughout the mouse embryo. This finding 
also points to a potential role of Id proteins in lung endothelial morphogenesis.  
 
Id1-/-Id3-/- lungs exhibit vascular defects in vivo and in culture 
The interesting expression patterns of Id genes led us to investigate the 
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Fig 2.1 Expression domains of Id1 and Id3 overlap with that 
endothelial marker CD31.
A. Representative photographs showing RNA in situ hybridization of 
Id1 and Id3 transcripts in E12.5 wildtype lungs. Dotted circles outline 
boundary between mesenchyme and epithelial layer in the lung lobe. 
Magnification 400x. B. Endothelial cell distribution as illustrated by 
CD31 immunohistochemistry of E12.5 wildtype lung. Note that both
the Id genes and CD31 are expressed in distal mesenchymal cells 
away from the epithelial layer. Magnification 400x.
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functional roles of these genes in embryonic lung vascular development. We 
examined whether loss of Id gene function in embryonic lungs under normal 
developing conditions would result in detectable vascular defects. E11.75 wildtype 
and Id1-/-Id3-/- lungs were collected and alteration in Pecam-1 expression was 
examined by immunohistochemistry. Staining revealed that there is no obvious 
change in Pecam-1 expression level or patterns in Id1-/-Id3-/- double knockout 
lung mesenchyme compared to the wildtype (data not shown). However, since 
major vascular development happens later than E11.5, it is critical to obtain Id1 
and Id3 double knockout lungs at later stage. Unfortunately, most Id1-/-Id3-/- 
embryos die before E12.5 due to brain hemorrhage (Lyden et al., 1999). To 
overcome this obstacle, we collected and cultured E11.5 Id1-/-Id3-/- double 
mutant lungs in vitro under hypoxic condition (van Tuyl et al., 2005) or in vivo 
under the renal capsule to allow recovery of more differentiated lung tissues for 
analysis. E11.5 wildtype and Id1-/-Id3-/- lungs were dissected out and cultured in 
hypoxic chambers with 3% oxygen for 48 hours. Lungs were then collected and 
expression of CD31/Pecam-1 was analyzed by immunohistochemistry. As shown 
by whole-mount CD31 immunostaining in Figure 2.2, the vascular density in 
cultured Id1-/-Id3-/- lungs is greatly reduced compared with wildtype lungs, 
suggesting impaired distal angiogenesis due to complete removal of Id function in 
lung endothelial cells. Moreover, section immunohistochemistry revealed that the 
capillary tubes in Id1-/-Id3-/- lungs appear to be more dilated and disrupted 
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Id1+/+Id3+/+                          Id1-/-Id3-/-
Fig 2.2 Id1-/-Id3-/- lungs display defects in endothelial 
morphogenesis under hypoxia culture condition.  
Whole mount immunostaining of CD31 to show the morphology of 
vascular network in the lung. Representative photographs showing
E11.5 wildtype and Id1-/-Id3-/- lungs at 48 hours post culture in 3% 
Oxygen. Magnification 400x.  The lungs devoid of Id gene function 
display reduced vascular density compared with wildtype control.
32
compared with Id1 single mutant (Id1-/-Id3+/+) lungs with two functional alleles of 
Id3 (Fig2.3, arrows). I observed that the reduced vascular density defect is 
recapitulated in the renal capsule experiment. As shown by section 
immunostaining for CD31/Pecam-1, there is marked reduction of CD31-positive 
endothelial cells in the grafted Id1-/-Id3-/- double knockout lung compared to 
wildtype lungs within the same capsule (Fig2.3). This finding suggests that Id1 
and Id3 appear to play an important role during vascularization of the embryonic 
lungs, consistent with their pivotal roles in brain vascularization.  
 
Id1-/-Id3-/- lungs show decreased MMP-2 expression in the mesenchyme in 
vivo and in culture 
Id1 has been shown to attenuate endothelial apoptosis rate in HUVEC cells 
(Nishiyama et al., 2005; Valdimarsdottir et al., 2002). In order to determine the 
contribution of apoptosis to the vascular defects observed in Id1-/-Id3-/- lungs, we 
examined the endothelial apoptotic profile in cultured wildtype and mutant lungs. 
Sections of cultured wildtype and Id1-/-Id3-/- lungs were stained with TUNEL (cell 
death marker) and CD31/Pecam-1 (endothelial marker). Double-labeling results 
showed that neither wildtype nor Id1-/-Id3-/- lung endothelial cells undergo 
extensive cell death, as very few TUNEL-positive cells co-stained with CD31 
(Fig2.4). This observation suggests that endothelial cell death is not a major event 
during lung vascular development and does not contribute significantly to the 
defects of angiogenesis in Id1 and Id3 double knockout lungs. 
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Fig 2.3 Impaired vascular development of Id1-/-Id3-/- lungs at both 
in vitro and in vivo culture conditions. 
CD31 immunostaining of lung sections of E11.5 Id1-/- and Id1-/-Id3-/-
lungs at 48 hours post hypoxia culture (left panel) or 6 days after renal 
capsule implantation. Magnification 200x.
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Fig 2.4 Endothelial apoptosis is not a major event during lung 
vascular development. 
Endothelial cell death detection in Id1-/-Id3+/+ and Id1-/-Id3-/- lungs by 
TUNEL (green) and CD31 (red) double-labeling. Representative 
sections are shown for E11.5 lungs at 48 hours post-hypoxia culture. 
Magnification 400x.
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We reasoned that compromised vascular development caused by lack of 
Id function might also be linked to defects in endothelial cell migration. Id1 and Id3 
has been shown to induce MMP-2 and MMP-9 expression, two pro-angiogenic 
MMP family genes that function to degrade ECM scaffolds during endothelial cell 
morphogenesis (Benezra et al., 2001; Coppe et al., 2004; Desprez et al., 1998; 
Sakurai et al., 2004). Hence we examined the expression of MMP-2 in cultured 
wildtype and Id1-/-Id3 -/- lungs by immunohistochemistry. Although we did not 
detect a significant change in MMP-2 level in freshly dissected E11.5 lungs 
(Fig2.5-A), MMP-2 expression was significantly upregulated after culturing for two 
days in hypoxic chambers (Fig2.5-B). Interestingly, we observed dramatic 
decrease of MMP-2 protein level in Id1-/-Id3-/- lung mesenchyme compared with 
Id1 single mutant controls (Fig. 2.5-B). In addition, double labeling of MMP-2 and 
CD31 revealed that endothelial CD31 expression in Id1-/-Id3-/- lungs rarely 
co-localized with reduced MMP-2 expression, suggesting that loss of Id function in 
endothelial cells results in downregulated MMP-2 protein synthesis (Fig 2.5-B). 
Taken together, our results indicate that expression of Id1 and Id3 in embryonic 
lung mesenchymal cells are required to maintain MMP-2 expression, which may 
facilitate endothelial cell migration. 
 
 
Discussion 
 
Great emphasis has been focused on the functions of Id proteins in 
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Fig 2.5 MMP-2 expression is compromised in Id1-/-Id3-/- lung 
mesenchyme under culture conditions.
Representative photographs MMP2 (red) and CD31(green) double-
immunostaining of E11.5 Id1-/- and Id1-/-Id3-/- lungs freshly dissected 
(A) or cultured for 48 hours in 3% Oxygen (B). Magnification 400x.
37
angiogenesis during embryonic brain development and during tumorigenesis, 
whereas little is known regarding their roles during endothelial morphogenesis in 
other organs. In this study, I have shown that Id1 and Id3 have overlapping 
expression patterns in embryonic lung mesenchyme and overlap with a region of 
active endothelial morphogenesis in the lung. Analysis of vascular defects in 
cultured or implanted Id1-/-Id3-/- lungs revealed that proper Id function is required 
for normal endothelial morphogenesis in the embryonic lung. The Id1 and Id3 
double knockout lung serves as an ideal model for studying Id function in 
angiogenesis, given the fact that no other known Id family proteins are expressed 
in the lung mesenchyme. Furthermore, by culturing Id1-/-Id3-/- lungs in vitro under 
hypoxic condition or in renal capsules, I was able to overcome the early 
embryonic lethality problem and obtain more differentiated double knockout lungs 
representing late pseudoglandular stages. This model system may be valuable for 
future investigations into the other roles of Ids such as neurogenesis and 
myogenesis during lung development.  
Id1 and Id3 are known to facilitate endothelial survival by either preventing 
senescence or apoptosis and by promoting proliferation (Alani et al., 2001; 
Nishiyama et al., 2005; Sharpless et al., 2001; Tang et al., 2002; Valdimarsdottir 
et al., 2002). In this study, I have shown that endothelial cells in the embryonic 
lung do not undergo extensive apoptosis (Fig2.4). Therefore it is unlikely that the 
anti-apoptotic function of Id proteins plays a key role during normal endothelial 
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morphogenesis in the embryonic lung. However since the endothelial cells are 
highly proliferative during development, it is reasonable to speculate that the 
presence of Id1 and Id3 is indispensable for maintaining proliferation of 
endothelial cells.  Further examination of the association between loss of Id 
function and alteration in endothelial proliferation is needed to establish the role of 
Id proteins in endothelial cell proliferation. 
The MMP family protein consists of 25 related endopeptidases. They are 
synthesized and secreted as precursor forms then activated upon proteolytic 
cleavage. The MMPs are primarily engaged in the regulation of ECM composition, 
with secondary functions in modulating growth factor bioactivities (Visse and 
Nagase, 2003). The crucial roles of MMP proteins in angiogenesis and metastasis 
have been well established through in vitro studies and tumor models (Bergers et 
al., 2000; Haas and Madri, 1999; Hiraoka et al., 1998; Pagenstecher et al., 2001; 
Pozzi et al., 2000; Vu et al., 1998). Numerous studies suggest that the MMPs may 
also be involved in lung vascular development, although detailed examination of 
the embryonic vascular network phenotypes in multiple MMP knockout mice is 
required to firmly establish the roles of MMPs in lung endothelial morphogenesis. 
MMP-2, MMP-9 and MMP-14 are all found to be highly expressed in the 
embryonic mouse lung mesenchyme during a period of extensive angiogenic 
activity (Kheradmand et al., 2002; Ryu et al., 2005). Mild defects in the alveolar 
space have been observed in MMP-2 null mice, an indication of an impaired 
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alveolization process that involves migration of capillary endothelial cells 
(Kheradmand et al., 2002). A premature capillary structure, a double capillary 
network forming on both sides of the septa, was also documented in MMP-14 null 
mice (Irie et al., 2005).  My finding that loss of Id1 and Id3 function results in 
decreased MMP-2 expression in embryonic lungs underscores the 
pro-angiogenic role of Id proteins. MMP-2 has been shown to be transcriptionally 
regulated by Id proteins in both cultured endothelial cell lines and in mouse tumor 
grafts (Benezra et al., 2001; Coppe et al., 2004; Ruzinova et al., 2003; Sakurai et 
al., 2004). Sequence analysis revealed that MMP-2 promoter activity is under 
direct repression by p16, a well-known downstream target of Id proteins. 
Therefore it is possible that the presence of Id1 and Id3 in the lung mesenchyme 
maintains MMP-2 expression by inhibiting its negative regulator p16 expression. 
Examination of alterations in p16 transcript level upon ablation of Id function in the 
lung may provide valuable information about the molecular connection between Id 
proteins and MMP-2.  
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CHAPTER III 
 
 
 
ID1 FUNCTION IN ENDOTHELIAL DAMAGE DURING BLEOMYCIN-INDUCED 
ACUTE LUNG INJURY 
 
 
 
Introduction 
 
Although Id1 is highly expressed in the lung mesenchyme during 
embryogenesis, its expression is downregulated after birth and is barely 
detectable in the normal adult murine lung, suggesting that Id1 function is likely not 
essential in healthy adult lungs. In agreement, Id1 loss-of-function mutant mice are 
viable and fertile under pathogen-free housing conditions (Yan et al., 1997). 
Upregulation of Id1 in bleomycin-treated rat lungs has been reported in previous 
studies although the detailed expression pattern and specific function of Id1 was 
not thoroughly investigated (Chambers et al., 2003). In this study, we found that 
upon bleomycin-induced injury, Id1 is upregulated in different lung cell types but 
predominantly in endothelial cells, suggesting a potential role of Id1 in these cell 
types upon lung injury. Loss of Id1 function in the lung endothelium resulted in 
increased vascular permeability and endothelial cell death after bleomycin 
instillation. Likewise, we found that Id1-/- lung microvascular endothelial cells 
showed decreased survival in culture. Taken together, our studies reveal a new 
function of Id1 as part of the self-defense response system in the lung, protecting 
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pulmonary endothelial cells from undergoing extensive damage upon bleomycin 
challenge. 
 
Experimental Procedures 
Mice and bleomycin treatment  
Id1 null mice (Id1-/-) (gift of Dr. Robert Benezra) and Tie1-Cre mice 
(Gustafsson et al., 2001) were bred in the C57BL/6J background and 
ShhCre-ZEG mice (Li et al., 2006) were bred in the C57BL/6J;129 background. 
For the Id1 time-course study, C57BL/6J mice (8-10 week old) were purchased 
from the Jackson Laboratory. Mice were treated with either saline or bleomycin 
(0.08U) by intratracheal injection in a total volume of 50ul saline (Lawson et al., 
2005b). The experimental protocol was reviewed and approved by the 
Institutional Animal Care and Utilization Committee at Vanderbilt University.  
 
Immunohistochemistry  
ShhCre-GFP embryonic lungs were fixed in 4% PFA for 5h at 4oC and 
embedded in OCT cryo embedding medium. 15um sections were cut and 
immunostained with Pecam-1 antibody (BD Pharmingen) followed by Alexa-568 
conjugated secondary antibody (Molecular Probe) for signal visualization. 
ShhCre-GFP adult lungs were perfused using phosphate-buffered saline (PBS), 
then inflated and fixed in 4% PFA for 5h at 4oC. Subsequently, OCT was injected 
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intratracheally into fixed lung to preserve the lung architecture. Lungs were 
embedded in OCT and 15um sections were collected and GFP fluorescence 
visualized using an Olympus BX60F5 microscope. 
Adult Lungs were perfused, inflated, excised, and fixed in 4% 
paraformaldehyde at 4oC overnight. Subsequently, lungs were embedded in 
paraffin blocks and 5 um sections were collected and processed for 
immunolabeling. Antibodies against smooth muscle alpha-actin (Sigma, 1:300), 
CD34 (Labvision, 1:100) and β-galactosidase (LacZ) (Sigma, 1:2000) were used 
for immunostaining. For general immunolabeling, slides were antigen-retrieved 
using citrate buffer (pH6.0) and incubated at 4oC overnight with primary antibody. 
Alexa-conjugated secondary antibodies or horseradish peroxidase 
(HRP)-conjugated secondary antibodies (Jackson ImmunoResearch) and HRP 
detection kit (Labvision) were used for signal visualization.  
For Id1 immunolabeling, lungs were perfused with phosphate-buffered 
saline (PBS) and fixed in EFA solution (100% ethanol, 37% formaldehyde and 
100% acetic acid at V/V ratio of 6:3:1) at 4°C for 5 hours. Subsequently, lungs 
were dehydrated and embedded in paraffin blocks and 5 um sections were 
collected and processed for immunolabeling. Slides were incubated at 4oC 
overnight with primary antibody, Id1 (Santa Cruz Biotechnology), at 1:6000. 
Detection was performed using polymer-HRP secondary antibodies (Zymed) 
diluted at 1:4 and visualized using the TSA Plus Fluorescence System (Perkin 
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Elmer) diluted at 1:200. Slides were counterstained with TO-PRO-3 (Invitrogen) to 
highlight nuclei. For double-labeling involving Id1, sequential immunostaining 
were performed instead of a one-step double-labeling. Confocal images were 
taken using the Zeiss Upright LSM510 Confocal microscope at the Vanderbilt Cell 
Imaging Core. Regular images were taken using the Olympus BX60F5 
microscope. 
 
Western blotting  
Left lungs of bleomycin-treated wildtype and Id1-/- mice were harvested 
and homogenized in RIPA lysis buffer at pH7.4. Protein lysates of 100ug each 
were resolved on SDS-polyacrylamide gels (Bio-Rad). Primary antibodies against 
Id1 were used for detection. Equal loading of protein samples was monitored by 
and normalized to the level of α-tubulin (Calbiochem-EMD Biosciences, 1:2000). 
Blots were analyzed using QuantityOne software (Bio-Rad). For western blotting 
using FACS-sorted cells, cells were immediately frozen in liquid nitrogen after 
collection. Sorted cells were lysed in RIPA buffer and loaded at 50ug/lane on 
SDS-polyacrylamide gels. Additional antibodies used for blotting were Pecam-1 
(BD Pharmingen, 1:500), TTF-1 (labvision, 1:200), Bcl-2 (Santa Cruz 
Biotechnology, 1:500), Bcl-xL (Santa Cruz Biotechnology, 1:500), MEK1/2 (Cell 
Signaling, 1:1000), phospho-MEK1/2  (Cell Signaling, 1:1000), ERK1/2  (Cell 
Signaling, 1:1000) and phospho-ERK1/2  (Cell Signaling, 1:1000). Blots were 
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scanned and quantified as described above.  
 
Pulmonary vascular permeability assay  
Vascular permeability was examined using the Evans blue extravasation 
method as previously described (Londhe et al., 2005). Briefly, Evans blue dye at 
20mg/kg body weight was injected into each animal via the retro-orbital sinus. 
Three hours after injection, lungs were perfused and homogenized in saline. 
Evans blue was extracted and quantified by dual wavelength at 620nm and 
740nm using Bio-Rad Smartspec3000. Corrected pulmonary Evans blue 
absorbance at 620nm was calculated as A620nm–(1.426xA740nm + 0.03). 
Permeability index was generated by dividing the corrected pulmonary Evans 
blue absorbance by the plasma Evans blue absorbance at 620nm.  
 
Pulmonary endothelial cell culture 
Adult lung microvascular endothelial cells were isolated and cultured as 
previously described (Pozzi et al., 2000). Briefly, lungs were perfused with 0.25% 
Trypsin (Mediatech) and 2ug/ml collagenase (Roche Applied Science). Perfused 
lungs were incubated at 37 oC for 20min. Then lung lobes were trimmed with a 
sterile scalpel and washed 10-20 times with 1ml DMEM medium containing 10% 
fetal bovine serum (FBS). Detached cells were collected and centrifuged at 2,000 
rpm. Cell pellet was washed once and resuspended in EGM2-MV medium 
(Cambrex) with 2% FBS. Cells were grown on 6-well dishes (BD Falcon) or 
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coverslips (Fisher) for 3 days before application of treatment. All cells were 
maintained at 37oC and 5% CO2 in a Hera Cell incubator unit (Kendro 
Laboratories). Cells from triplicate wells were harvested for p21 immunodetection 
by Western blotting as above.  
 
Terminal deoxynucleotidyl transferase–mediated dUTP Nick End Labeling 
(TUNEL) 
For cell death detection in lung tissue sections, paraformaldehyde-fixed 
paraffin sections were boiled in citrate buffer (pH6.0) for 20min and apoptotic cells 
were detected by TUNEL using the In situ Cell Death Detection Kit (Chemicon) 
according to manufacturer’s protocol. Detection was performed using an 
HRP-conjugated secondary antibody and visualized using the TSA Plus 
Fluorescence System (Perkin Elmer).  Slides were subsequently double-stained 
with CD34 to mark endothelial cells.  
For TUNEL staining of cultured endothelial cells, freshly isolated lung 
microvascular endothelial cells were grown in culture dishes for 3 days before 
treatment with 250ng/ml bleomycin for 6 hours. The bleomycin-containing media 
were then removed and replaced with fresh EGM2-MV media for 3 hours. The 
cells were subsequently stained with TUNEL according to manufacturer’s 
protocol.  
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Quantification of apoptotic endothelial cells by FACS analysis  
For FACS analysis on freshly isolated murine lung microvascular 
endothelial cells, saline or bleomycin-treated lungs were perfused with 25units/ml 
dispase (BD Biosciences) plus 2ug/ml collagenase (Roche Applied Science) then 
incubated in digestive solution at 37oC for 20min. The lungs were then minced and 
a single cell suspension was obtained by passing cells through a 40um cell 
strainer (BD Falcon).  After centrifugation at 1000rpm for 5min, collected cells 
were resuspended in Red Cell Lysis buffer (Lorimore et al., 2001) and incubated at 
room temperature for 10min. The cells were then washed twice with PBS and 
stained with apoptotic marker using the Annexin-5 Apoptosis Detection Kit 
(Biovision) according to the manufacturer’s protocol.   
For FACS analysis on cultured lung microvascular endothelial cells, freshly 
isolated lung microvascular endothelial cells were grown in culture dish for 3 days 
before treatment with 250ng/ml bleomycin for 6 hours. Cells were collected by  
dispase/collagenase digestion and labeled with Annexin-5 to mark apoptotic cells. 
FACS sorting was performed at the Vanderbilt HHMI Flow Cytometry Facility. 
 
Statistics 
To assess differences among groups, statistical analyses were performed 
using a one-way analysis of variance (ANOVA) with Microsoft Excel (Microsoft 
Corporation) and significance accepted at p<0.05. Results are presented as mean 
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+/- SEM. 
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Results 
Id1 expression is significantly upregulated in the lung upon bleomycin 
injury 
Although Id1 is highly expressed in the embryonic lung mesenchyme 
during a period of epithelial-mesenchymal interaction (Jen et al., 1996), its 
expression is not detectable in normal adult lung tissue sections by 
immunohistochemistry (Fig. 3.1, Saline 1wk). By Western blot analysis, which is a 
more sensitive detection method using whole lung homogenates, we detected 
weak Id1 expression (Fig 3.2, Saline). To investigate whether Id1 expression is 
upregulated upon pulmonary insult, we treated 8 week-old adult wildtype mice 
with a single 0.08 unit dose of bleomycin intratracheally and harvested lungs at 1 
week post-bleomycin for Id1 immunohistochemistry. Interestingly, we found 
significant induction of nuclear Id1 expression in the bleomycin-treated wildtype 
lung compared with saline control (Fig. 3.1, Bleo 1wk). The specificity of Id1 
antibody staining was confirmed using Id1-/- lung as a negative control (Fig 3.1, 
Bleo 1wk, Id1-/-). To evaluate the level and time course of Id1 induction in 
wildtype mice, we examined Id1 protein levels from lung samples collected at 1, 2 
and 3 weeks after bleomycin instillation (N=3, Fig. 3.2).  As shown by Western 
blotting, Id1 expression is significantly upregulated at 1 week post-bleomycin 
compared with saline control, and its upregulation is maintained for 2 and 3 weeks 
post-bleomycin (Fig. 3.2).  
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Fig 3.1 Id1 expression is significantly upregulated in the 
adult lung upon bleomycin injury. Representative 
photographs showing sections from 8 week-old wildtype and 
Id1-/- lungs treated with saline or 0.08U bleomycin and 
collected after 1 week. Sections were immunostained with 
Id1 (red) and nuclei were counterstained with TO-PRO3 
(green). Note the nuclear Id1 expression in wildtype lungs 
treated with bleomycin but not in saline controls. The 
specificity of Id1 staining is confirmed by using bleomycin-
treated Id1-/- lungs as negative control. Magnification 400x 
and 1000x. 
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AB
Fig 3.2 Id1 expression is significantly upregulated in the 
adult lung upon bleomycin injury.
A. Protein extracts from 8 week-old C57BL/6 wildtype 
lungs or Id1-/- lungs treated with saline or 0.08U bleomycin 
and collected after 1, 2 and 3 weeks (N=3 for each time 
point) were immunoblotted with Id1 antibody. α-tubulin was 
used as a loading control.  B. Densitometric measurements 
of Id1 bands were performed and normalized to the density 
of α-tubulin bands. 
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Id1 protein expression is upregulated predominantly in the lung 
endothelium  
We found that a large proportion of Id1 expression localized to lung 
endothelial cells as revealed by double immunolabeling with Id1 and endothelial 
marker CD34, which labels the capillary bed (Balyasnikova et al., 2005). As 
shown in Fig. 3.3, Id1-positive cells displayed nuclear Id1 expression surrounded 
by membrane and cytoplasmic expression of CD34 (Fig. 3.3, arrows). There were 
only a few Id1-expressing cells that appeared to be CD34-negative (Fig. 3.3, 
arrowhead). To determine the fraction of Id1 protein expression level derived from 
endothelial cells, we performed fluorescence-activated cell sorting (FACS) 
analysis of Tie1Cre-GFP labeled endothelial cells to quantify the relative level of 
endothelial-derived Id1 expression by Western blotting. Tie-1 is a receptor 
tyrosine kinase expressed during early stages of vascular development and Tie-1 
promoter driven Cre-GFP reporter expression specifically marks endothelial cells 
in the adult mice (Gustafsson et al., 2001). By crossing Tie1Cre to ZEG mouse, 
which contains a transgene harboring a conditional Green Fluorescent Protein 
(GFP) reporter that is activated in the presence of Cre recombinase (Novak et al., 
2000), mice were indelibly marked by GFP in all lung endothelial cells. The 
enrichment of the FACS-sorted endothelial cells was confirmed by Western 
blotting with endothelial marker, Pecam-1 (Fig. 3.6-A). By Id1 Western blot 
analysis, we found that the GFP-positive endothelial cell population expressed a 
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Fig 3.3 Id1 expression is upregulated prominently in the 
injured lung endothelium. 
Representative photographs showing sections from 8 week-
old wildtype lungs at 1 and 2 weeks post-bleomycin. 
Sections were double-stained with Id1 (red) and endothelial 
marker CD34 (green) antibodies. Arrows in the figures point 
to representative Id1-expressing endothelial cells; note the 
membrane and cytoplasmic CD34 staining which wraps 
around the nuclear Id1 staining. Arrowheads point to Id1-
expressing non-endothelial cells. Magnification: low at 400x 
and high at 1000x.
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relatively much higher level of Id1 compared with the non-endothelial cell 
population. At 1 week post-bleomycin, we determined that Id1 expression level in 
the lung endothelial population was upregulated up to 11-fold compared to saline 
control based on normalized densitometric measurements (Fig. 3.6-A). We also 
determined that about 86% of total Id1 expression level was derived from the lung 
endothelial fraction (Fig.3.6-A). In contrast, bleomycin-treated non-endothelial 
cells displayed only about 3-fold upregulation. This significant contribution in Id1 
expression level by the endothelial cell population persisted at 2 weeks 
post-bleomycin, with approximately 80% of total Id1 expression level derived from 
endothelial cells (Fig. 3.6-C).  
To examine Id1 expression in the alveolar epithelium, we took advantage 
of the Sonic hedgehog (Shh)-Cre mouse line that we had generated which marks 
all lung cells of epithelial origin (Fig. 3.4-A) (Li et al., 2006). Shh is expressed early 
in the epithelium of the embryonic lung primordium (Bellusci et al., 1997; Bitgood 
and McMahon, 1995; Litingtung et al., 1998; Urase et al., 1996). Mice generated 
by crossing Shh-Cre to ROSA26R mouse, which contains a transgene harboring 
a conditional LacZ reporter that is activated in the presence of Cre recombinase, 
are indelibly marked in all lung epithelial cells by LacZ reporter expression. 
Subsequently, all lung epithelial cells are marked by LacZ as shown at embryonic 
stages E11.5, E15.5 and in the normal adult bronchial and alveolar epithelium 
(Fig. 3.4-A). By double immunolabeling, we observed that Id1-expressing cells 
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Fig 3.4 Id1 expression is not significantly upregulated in 
bleomycin-exposed epithelium. 
A. Distribution of GFP-labeled epithelial cells (green) in 
embryonic lungs at E11.5 and E15.5 and in the adult lung at 
6 weeks. Embryonic lung sections were double-stained with 
endothelial marker Pecam-1 (red). Note that GFP expression 
is strictly confined in epithelial cells throughout 
development and is excluded from the Pecam-1-positive 
endothelial domain. GFP expression was detected in the 
adult bronchial epithelium (Br) and alveolar epithelial cells. 
Vessel (V) was negative. Magnification 200x.  B.
Representative photographs showing sections from 8 week-
old wildtype ShhCre-R26R lungs at 1 week post-bleomycin. 
Sections were double-stained with Id1 (red) and epithelial 
marker Shhcre-LacZ (green). Arrows in the figures point to 
representative Id1-expressing epithelial cells. Arrowheads 
point to Id1-expressing non-epithelial cells. Magnification: 
600x.
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showed very little colocalization with LacZ+ epithelial cells both in the bronchial 
epithelium and in the alveolar bed (Fig. 3.4-B, arrow). Most Id1-expressing cells 
do not colocalize with epithelial LacZ expression (Fig. 3.4-B, arrowheads). By 
counting ten non-overlapping fields of Id1 and LacZ double-stained sections, we 
determined that only about 3% of all Id1-expressing cells were LacZ positive. 
Similar to the strategy used in Fig. 3.6-A, we utilized ShhCre-ZEG reporter mice to 
selectively identify GFP-positive epithelial cells in the lung by FACS analysis. The 
enrichment of epithelial cells was confirmed by Western blotting with an epithelial 
marker, TTF-1 (Nakamura et al., 2002). As shown in Fig. 3.6-B, bleomycin-treated 
GFP-positive epithelial cells displayed less than 2-fold upregulation of Id1 while 
the non-epithelial fraction displayed up to 9-fold increase in Id1 expression level. 
These results indicate that Id1 is not significantly upregulated in epithelial cells of 
bleomycin-treated lungs, which is consistent with the immunohistochemical data 
(Fig3.4).  
We observed a few fibroblastic-like cells expressing Id1 as has been 
reported previously in the rat lung (Chambers et al., 2003). However, Id1 
expression was not detected in the majority of lung myofibroblasts located in 
fibrotic foci at two weeks post-bleomycin (Fig. 3.5, arrowheads). We observed 
expression of Id1 in few smooth muscle actin-positive myofibroblasts (Fig. 3.5, 
arrow). Collectively, our data suggest that over 80% of total Id1 protein expression 
level in the lung, at 1 and 2 weeks after bleomycin exposure, is derived from the 
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Fig 3.5 Id1 expression is not significantly upregulated in 
bleomycin-exposed lung fibroblasts
Representative photographs showing sections from 8 week-
old wildtype lungs at 2 weeks post-bleomycin. Sections 
were double-stained with Id1 (red) and myofibroblast 
marker, Smooth muscle actin (SMA) (green). Arrows in the 
figures point to Id1-expressing myofibroblast cell. 
Arrowheads point to Id1-expressing non-myofibroblast cells. 
Magnification: 400x.
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Fig 3.6 Id1 expression is upregulated prominently in the 
injured lung endothelium. 
Eight week-old wildtype Tie1Cre-ZEG or ShhCre-ZEG 
lungs were treated with saline or 0.08U bleomycin and 
collected after 1 week or 2 weeks; lung cells were 
sorted into GFP+ and GFP- group by FACS. Protein 
extracts were immunoblotted with Id1 and α-tubulin as 
the loading control. Purity of the fractions was 
confirmed by immunoblotting with endothelial marker 
Pecam-1 or epithelial marker TTF-1. Densitometric 
measurements of Id1 bands were performed and 
normalized to the density of α-tubulin bands and 
values indicating differential levels of expression are 
shown as columns on the right. Note the dramatic 
upregulation of Id1 protein level in endothelial cells 
from bleomycin-treated lungs compared with the non-
endothelial fraction and saline controls.
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endothelial cell population and less than 20% is derived from other lung cell types, 
possibly immune cells which are involved in lung injury by bleomycin and have 
been shown to express Id1 (Leeanansaksiri et al., 2005). Our finding indicates 
that epithelial and fibroblastic cells contribute minimally to the Id1 expression level 
in bleomycin-injured lungs. In sum, these findings point to potential roles of Id1 in 
different lung cell populations, in particular, the endothelial cells, upon 
bleomycin-induced injury.  
 
Id1 is required for survival of cells of the lung endothelium exposed to 
bleomycin  
Since lung endothelial cells comprised a large fraction of Id1-expressing 
cells after bleomycin exposure, we investigated the functional role of Id1 in 
endothelial cells. To assess endothelial dysfunction in Id1-/- mutant lungs, we first 
evaluated change in vascular permeability by measuring the extravasation of 
Evans blue dye which, when injected via the retro-orbital sinus, can immediately 
complex with circulating albumin (see Methods). Accumulation of albumin-dye 
complexes within the lung parenchyma was quantified spectrophotometrically and 
used as an indicator of vascular macromolecular leakage (Londhe et al., 2005). 
We found that wildtype lungs showed significant leakage of Evans Blue at 1 week 
post-bleomycin when compared to saline-treated lungs (Fig. 3.7). However, 
vascular leakage is more pronounced in Id1-/- mutants, showing a 58% increase 
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Fig 3.7 Bleomycin-injured Id1-/- lungs display increased 
endothelial barrier dysfunction, elevated endothelial 
apoptosis.  A. Increased vascular permeability in bleomycin-
challenged Id1-/- lungs. Pulmonary vascular permeability of 
saline or bleomycin-treated 8 week-old wildtype or Id1-/-
lungs was determined by Evans blue extravasation assay (n=3 
for each group). Note 58% increase in Evans Blue dye leakage 
in injured Id1-/- lungs compared with wildtype lungs. 
Asterisks denote a significant difference (p<0.05) between 
wildtype and Id1-/- lungs at 1 week post-bleomycin.  B.
Endothelial cell death detection in wildtype and Id1-/- lungs 
by TUNEL (red) and CD34 (green) double-labeling. 
Representative sections are shown for lungs at 1 week post-
bleomycin or saline. Magnification 400x.
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in dye content when compared to bleomycin-treated wildtype lungs (N=3, Fig. 
3.7-A), indicating increased disruption of the endothelial barrier in the absence of 
Id1 function. 
Id1 has been shown to attenuate apoptotic cell death in human umbilical 
vein endothelial cells (Nishiyama et al., 2005). Therefore, it is conceivable that 
increase in endothelial permeability in Id1-/- lungs is, at least in part, contributed 
by increase in endothelial cell death. To determine the level of endothelial cell 
death in Id1-/- and wildtype lungs at 1 week after bleomycin instillation, we first 
performed TUNEL and CD34 double immunolabeling. We found that there was 
significantly higher number of apoptotic endothelial cells in Id1-/- compared with 
wildtype (Fig. 3.7-B). For quantitative analysis, we performed FACS to measure 
the percentage increase in apoptotic endothelial cells that are double positive for 
Tie1-GFP (endothelial) and annexin-5 (apoptotic) in Id1-/- lungs compared with 
wildtype. In bleomycin-treated lungs, FACS analysis indicated that wildtype and 
Id1-/- contained, respectively, an average of 11.7% and 16.1% apoptotic 
endothelial cells that were double positive for GFP and annexin-5 (Fig. 3.8).  
Therefore, there was an average increase of 37.6% in apoptotic endothelial cells 
in Id1-/- relative to the wildtype level (N=3). Saline-treated lungs showed relatively 
low level of apoptotic endothelial cells and were not significantly different in both 
genotypes (Fig. 3.8). This result clearly indicates a significant rise in apoptotic 
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Fig 3.8 Bleomycin-injured Id1-/- lungs display increased 
endothelial apoptosis.
Flow cytometric counting of apoptotic endothelial cells in 
wildtype or Id1-/- Tie1Cre;ZEG lungs at 1 week post-
bleomycin or saline. A. Representative dotspot graphs 
showing cell sorting results of 10,000 lung cells, using 
annexin-5 as the cell death marker and GFP as the endothelial 
marker. The upper right quadrant represents apoptotic 
endothelial cells. B. Statistic representation of the sorting 
results from 3 independent experiments (N=6). Note there is 
an average of 37.6% increase in endothelial cell death in 
injured Id1-/- lungs compared with wildtype lungs. Asterisks 
denote a significant difference (p<0.05) between wildtype 
and Id1-/- lungs. 
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endothelial cells in Id1-/- mutant mice after bleomycin treatment, suggesting an 
important role of Id1 in preventing endothelial cell death upon injury.  
Collectively, our findings indicate that Id1 plays a key role in the survival of 
cells of the lung endothelium after exposure to bleomycin and loss of Id1 function 
results in increased endothelial apoptotic cell death which leads to severe 
endothelial damage.  
 
Id1-/- lung microvascular endothelial cells display increased cell death in 
the presence of bleomycin in culture 
To further examine the role of Id1 in endothelial cell function and cell death 
induced by bleomycin, we carried out cell culture experiments using freshly 
isolated lung microvascular endothelial cells (LMVECs) from both wildtype and 
Id1-/- lungs. Cultured wildtype LMVECs expressed a moderate level of Id1 and 
this expression was further increased after bleomycin challenge (Fig. 3.9-A). We 
also observed that while freshly dissociated wildtype LMVECs could be passaged 
three times in culture, it was not possible to passage Id1-/- LMVECs after first 
plating which is likely due to their reduced growth potential. Wildtype and Id1-/- 
LMVEC cultures grown for 3 days were treated with 250ng/ml bleomycin for 6 
hours and analyzed by TUNEL or double-labeled with Tie1Cre-GFP (endothelial 
reporter) and annexin5-Cy3 (apoptotic marker) and sorted by FACS analysis to 
quantify the level of apoptotic endothelial cells in culture (N=3). Consistent with 
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Fig 3.9 Id1-/- lung microvascular endothelial cells 
display reduced survival in culture   
A. Id1 is upregulated in endothelial cells by bleomycin in 
vitro. Western blotting showing Id1 level from wildtype 
primary LMVECs treated with saline or 250ng/ml 
bleomycin for the indicated time points. Values represent 
relative fold change of Id1 protein level normalized to the 
density of a-tubulin bands.   B. Cell death detection of 
wildtype and Id1-/- primary LMVECs by TUNEL (red) and 
Tie1Cre-GFP (green) double labeling. Representative 
photographs are shown for cell cultures treated with 
250ng/ml bleomycin for 6 hours followed by no bleomycin 
for 3 hours. Magnification 100x. 
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TUNEL staining which showed significantly more apoptotic cells in Id1-/- LMVECs 
(Fig. 3.9-B), Id1-/- LMVECs displayed an average of 17.3% apoptotic endothelial 
cells compared with 8.2% in wildtype (Fig. 3.10). These results indicate that Id1 
plays a crucial role in LMVEC survival in culture and are consistent with the 
functional role of Id1 in bleomycin-injured lungs in vivo. 
We reasoned that increased endothelial cell apoptosis may be linked to 
decrease in the levels of Bcl-2 family proteins, specifically Bcl-2 and Bcl-xL, which 
have been shown to be regulated by Id1 in several cancer cell lines (Ling et al., 
2003; Cheung et al., 2004; Hui et al., 2006). Since Bcl-2 proteins are well-known 
anti-apoptotic molecules, they may serve as a potential downstream effector of 
Id1 in the process of endothelial maintenance.  Hence we examined the 
expression of Bcl-2 and Bcl-xL in bleomycin-exposed wildtype and Id1-/- LMVECs 
by Western blotting. Although we did not detect significant difference in Bcl-xL 
level in Id1-/- endothelial cell population compared with wildtype, Bcl-2 expression 
was significantly higher in wildtype LMVECs after bleomycin exposure. (Fig. 3.11) 
This finding strengthens the notion that Id1 can inhibit cell apoptosis by 
modulating Bcl-2 expression. Previous studies suggest that upregulation of Bcl-2 
by Id1 may indirectly go through Ras/MEK/ERK pathway (Chang et al., 2003; 
Rivo et al., 2007). By Western blotting of phosphor-MEK and phosphor-ERK, we 
found that the activity of Ras/MEK/ERK pathway was also decreased, in 
concomitant with the reduction of Bcl-2 protein level. Taken together, our results 
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Fig 3.10 Id1-/- lung microvascular endothelial cells display 
reduced survival in culture. 
Flow cytometric counting of apoptotic endothelial cells in 
wildtype or Id1-/- Tie1Cre-ZEG LMVECs treated with saline 
or 250ng/ml bleomycin for 6 hours.  A. Representative 
dotspot graphs showing the results of cell sorting, at 10,000 
cells, each using annexin-5 as the cell death marker and GFP 
as the endothelial marker. The upper right quadrant represents 
apoptotic endothelial cells.  B. Statistic representation of the 
sorting results from 3 independent experiments (N=3). Note 
that there is nearly 2-fold increase in endothelial cell death in 
Id1-/- LMVECs compared with wildtype. Asterisks denote a 
significant difference (p<0.05) between wildtype and Id1-/-
cells.
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Fig 3.11 Id1-/- lung microvascular endothelial cells show 
reduced Bcl-2 level and MEK/ERK activity. 
Western blotting of cell lysates collected from wildtype or 
Id1-/- primary LMVECs (N=6 lungs for each genotype) 
treated with 250ng/ml bleomycin for 6 hours. Note that Bcl-2 
level is significantly decreased in LMVECs in the absence of 
Id1 function as opposed to the level of Bcl-xl, which remains 
unaltered. The MEK/ERK signaling pathway is also affected 
in Id1-/- endothelial cells, based on lower levels of 
phosphorylated MEK/ERK.
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indicate that upregulation of Id1 expression appears to inhibit lung endothelial cell 
death by activating Ras/MEK/ERK pathway and in turn inducing anti-apoptotic 
protein Bcl-2 expression. 
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Discussion 
In this study, we demonstrated that although Id1 was barely detectable in 
the normal adult lung, its protein expression was significantly upregulated 
predominantly in cells of the lung endothelium in response to bleomycin exposure. 
This new finding prompted us to investigate the contributory role of Id1 in 
bleomycin-injured lung endothelium. To this end, in addition to morphological and 
immunohistochemical approaches, we performed FACS analysis, which is a more 
rigorous and quantitative method, to specifically isolate endothelial or epithelial 
lung cell population from whole lungs by taking advantage of available transgenic 
reporter mouse lines.  
Bleomycin-induced lung injury and fibrogenesis, like many other types of 
lung injury, is almost always accompanied by increase in vascular permeability 
suggesting that vascular endothelial integrity and function are compromised. Our 
finding that bleomycin exposed Id1-/- lungs showed increased vascular 
permeability suggests that Id1 may play a critical role in maintaining endothelial 
integrity and function. Consistent with this notion, we demonstrated decreased 
endothelial cell survival in Id1-/- lungs injured by bleomycin compared with 
wildtype. In addition, cell culture experiments using freshly dissociated lung 
microvascular endothelial cells from Id1-/- lungs also showed significantly 
reduced survival potential compared with wildtype lung endothelial cells. Taken 
together, these observations revealed that one critical role of Id1 is to maintain 
71
pulmonary endothelial integrity by preventing endothelial cell death upon insult. 
Since Id1 function has been linked to cell proliferation, we also examined 
the change in endothelial proliferation in wildtype and Id1-/-lungs after bleomycin 
treatment. Results from double labeling with PCNA and CD34, to detect 
proliferating endothelial cells, revealed that the lung endothelium is relatively 
quiescent and did not appear to become highly proliferative upon bleomycin 
treatment.  In addition, we did not find significant differences in endothelial 
proliferation in Id1-/- compared with wildtype at 1 week after bleomycin (N=3), 
suggesting that Id1 is unlikely to play a major role in endothelial cell proliferation 
after lung injury (data not shown).  
FACS and double immunohistochemical labeling demonstrated that 
upregulation of Id1 expression was infrequently detected in epithelial and 
fibroblast cells, in contrast with Id1 upregulation in cells of the lung endothelium 
exposed to bleomycin. We determined that less than 20% of Id1 expression in 
bleomycin-exposed lungs was derived from non-endothelial cells; the identity of 
this lung cell population and the role of Id1 in that population remain to be 
determined. Id1 was shown to be moderately expressed in a subgroup of immune 
cells such as the macrophages and granulocytes (Leeanansaksiri et al., 2005). 
Therefore, Id1 may also be involved in the inflammatory response of lungs upon 
injury, which in turn can contribute to fibrogenesis. Therefore, it remains possible 
that loss of Id1 function in different lung cell populations and circulating cells may 
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also contribute to increased lung fibrogenesis induced by bleomycin in Id1-/- 
mutant lungs. 
Bmp signaling has been strongly implicated in Id gene induction in a 
number of cell types including endothelial cells (Hollnagel et al., 1999; Itoh et al., 
2004; Valdimarsdottir et al., 2002) and vascular endothelial growth factor (VEGF) 
has also been shown to induce Id1 and Id3 in bone marrow-derived endothelial 
precursor and hematopoietic cells (Lyden et al., 2001). Both signaling pathways 
are promising candidates for activating Id1 expression in the lung endothelium 
upon bleomycin injury, although the actual in vivo signals remain to be identified. 
Signalings mediated by TGF-β1 and TNF-α are known to play key roles in many 
types of lung diseases including bleomycin-induced pneumopathy in animal 
models (Bartram and Speer, 2004; Cutroneo and Phan, 2003; Nakao et al., 1999; 
Pittet et al., 2001; Santana et al., 1995; Wang et al., 2002; Zhao et al., 2002). 
Interestingly, TGF-β1 can exert long-term repression of Id1 expression in a 
number of cell types (Chambers et al., 2003; Kang et al., 2003; Kowanetz et al., 
2004) , suggesting that TGF-β could potentially antagonize Id1 expression in the 
course of lung pathogenesis. TNF-α has also been implicated in the regulation of 
Id expression in astrocytes during inflammatory injury of the central nervous 
system (Goumans et al., 2002; Kang et al., 2003; Tzeng et al., 1999). Thus, there 
may be a balance between Id1-inducing and Id1-repressing mechanisms in the 
bleomycin-injured lung. Therefore, future identification of signals that modulate 
73
Id1 expression in bleomycin-induced lung injury will improve our understanding of 
the regulatory mechanisms underlying Id1 function in lung injury and fibrosis.  
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CHAPTER IV 
 
 
 
THE INDUCTION AND FUNCTION OF ID1 IN OTHER ACUTE LUNG INJURY 
MODELS 
 
 
 
Introduction 
 
Our finding that Id1 plays a critical role in endothelial survival in the mouse 
endotracheal bleomycin injection model also implicates a key role of Id1 and the 
lung endothelium in the pathogenesis of acute lung injury (ALI).  In order to 
obtain a better understanding of the general involvement of Id1 in ALI, we 
extended the study of Id1 function in endothelial damage using other ALI models. 
Cecal ligation & puncture (CLP) and intravenous injection of bleomycin are both 
broadly used methods to induce acute lung injury. By generating inflammation or 
cell death in blood vessels, these methods of introducing insults directly target the 
endothelium (Azuma et al., 2000; Ebong et al., 1999; Guo et al., 2002; Laudes et 
al., 2004). These alternative approaches could circumvent the possible side 
effects of injured lung epithelium on endothelial injury as is the case with the 
endotracheal bleomycin model. Intratracheal injection of lipopolysaccharide (LPS) 
is another commonly used method to investigate the effect of a localized insult in 
the generation of ALI (Thorn, 2001). By examining Id1 expression and analyzing 
its function in several ALI models, we were able to complement our previous 
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observations and thus provide strong support that Id1 is upregulated upon insult 
to the lung endothelium and may serve to promote lung endothelial survival in ALI.  
 
Experimental Procedures 
 
Mouse models and treatment  
Wildtype mice used in this study were bred in the C57BL/6J background. 
For tail-vein injection of bleomycin, the 6 week-old mouse was placed in a 50 ml 
conical tube with its tail exposed through an opening in the cap. The dorsal tail 
vein was visualized by brief warming at 42oC using a heating lamp.  Saline or 
bleomycin (2.5U per animal) was then administrated by intravenous injection into 
the tail vein using a total volume of 300ul solution (Lawson et al., 2005b). For 
intratracheal injection of LPS, mice were treated with either saline or LPS (50ug 
per animal) injected into the surgically-exposed trachea using a total volume of 
50ul saline (Lawson et al., 2005b).  Cecal ligation and puncture was performed 
as described previously (Baker et al., 1983).  Briefly, mice were anesthetized 
and a midline incision was made to expose the cecum and adjoining intestine. 
The cecum was then tightly ligated at the base and punctured twice with a 
19-gauge needle. The incision was closed afterwards and mice were left for the 
indicated number of hours before sample collection. The experimental protocol 
was reviewed and approved by the Institutional Animal Care and Utilization 
Committee at Vanderbilt University. 
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Immunohistochemistry 
Lungs were perfused with phosphate-buffered saline (PBS) and fixed in 
4% PFA solution at 4°C for 5 hours. Subsequently, lungs were dehydrated and 
embedded in paraffin blocks and 5 um sections were collected and processed for 
immunolabeling. Slides were incubated at 4oC overnight with primary antibody Id1 
(1:1500) or MPO (1:300). Detection was performed using polymer-HRP 
secondary antibodies (Zymed) diluted at 1:2 and HRP detection kit (Labvision) 
were used for signal visualization. Slides were counterstained with Hematoxylin 
(Sigma) to highlight nuclei. Regular images were taken using the Olympus 
BX60F5 microscope. 
 
Pulmonary vascular permeability assay  
Vascular permeability was examined using the Evans blue extravasation 
method as previously described (Londhe et al., 2005). Briefly, Evans blue dye at 
20mg/kg body weight was injected into each animal via the retro-orbital sinus. 
Three hours after injection, lungs were perfused and homogenized in saline. 
Evans blue was extracted and quantified by dual wavelength at 620nm and 
740nm using Bio-Rad Smartspec3000. Corrected pulmonary Evans blue 
absorbance at 620nm was calculated as A620nm–(1.426xA740nm + 0.03). 
Permeability index was generated by dividing the corrected pulmonary Evans 
blue absorbance by the plasma Evans blue absorbance at 620nm.  
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Neutrophil Counting 
Slides of MPO-stained lung tissue were randomized and evaluated on ten 
sequential, non-overlapping fields (magnification, 400X) of lung parenchyma for 
each specimen. Counting of MPO-positive cells was performed blinded to the 
genotype and treatment groups. Results were presented as the average number 
of MPO-positive cells (neutrophils) per 400x field. 
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Results 
 
Id1 expression is significantly upregulated in the lung in different lung 
injury models 
To investigate whether Id1 expression is upregulated upon pulmonary 
insult caused by different insults, we treated adult wildtype mice using three 
different methods (Cecal ligation-puncture, Tail-vein injection of bleomycin and 
intratracheal injection of lipopolysaccharide) that are known to induce acute lung 
injury. Interestingly, we found significant induction of nuclear Id1 expression in the 
treated lungs compared with control groups in all three treatment methods (Fig. 
4.1). The expression pattern of Id1 appears to be in endothelial-like cells, 
consistent with what we observed in the intratracheal injection of bleomycin model. 
This interesting finding suggests that Id1 is generally involved in acute lung injury 
regardless of the pathological cause.  
 
Loss of Id1 function is associated with increased lung vascular permeability 
in CLP-induced lung injury 
Since we obtained similar expression patterns of Id1 in CLP-treated lungs 
compared to intratracheal-bleomycin treated lungs, we hypothesized that the 
upregulated Id1 in the lung in CLP models may also have a cytoprotective role in 
endothelial cells. To examine the extent of endothelial damage in Id1-/- mutant 
lungs, we evaluated the change in vascular permeability by measuring the 
extravasation of Evans blue dye, the same method utilized in the intratracheal 
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Fig 4.1 Id1 expression is significantly upregulated in the 
adult lung upon injury of different causes.
Representative photographs showing Id1 
immunohistochemistry of lung sections from wildtype lungs 
with different treatment. Sections were counterstained with 
hematoxylin to highlight nuclei. Note the nuclear Id1 
expression in treated wildtype lungs but not in saline controls.
Magnification 400x.
80
bleomycin model. We found that Id1-/- lungs showed significantly more leakage of 
Evans Blue at 8-hour post-CLP treatment when compared to wildtype lungs (Fig 
4.2, N=3), This result indicates that increased disruption of the endothelial barrier 
may be the consequence of ablated Id function, supporting the notion that Id1 has 
a cytoprotective role in endothelial cells. 
 
Loss of Id1 function in CLP-treated lungs results in increased neutrophil 
accumulation 
Since the inflammatory response in CLP-challenged mice contributes 
significantly to increased lung injury, we further analyzed the population of 
inflammatory cells in Id1-/- lung alveolar space and interstitium compared with 
wildtype at 4 and 8 hours after CLP treatment. We performed immunostaining of 
myeloperoxidase (MPO) to identify infiltrated neutrophils in the alveolar space. As 
shown in Fig 4.3-A, we detected significant difference in the inflammatory 
response between wildtype and Id1-/- lungs at 8 hours post-CLP treatment, 
indicated by increased MPO-positive cells in Id1-/- lungs. For semi-quantitative 
analysis, cell counts were performed on multiple fields and the degree of 
inflammation was determined as the number of MPO-positive cells per field. As 
illustrated in Fig 4.3-B, although no difference was observed at the 4-hour time 
point with the highest level of neutrophil attachment, Id1-/- lungs showed 
significant increase in MPO-positive cells at 8-hour post-CLP treatment compared 
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Vascular Permeability Assay (CLP-19G-8h)
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Fig 4.2 Id1-/- lungs from CLP-treated mice display 
increased endothelial barrier dysfunction,.  
Evans blue extravasation assay showing increased vascular 
permeability in injured Id1-/- lungs. Pulmonary vascular 
permeability of 8 hour CLP-treated wildtype or Id1-/- lungs 
was determined by Evans blue extravasation assay (n=3 for 
each group). Note nearly two-fold increase in Evans Blue dye 
leakage in injured Id1-/- lungs compared with wildtype lungs. 
Asterisks denote a significant difference (p<0.05) between 
wildtype and Id1-/- lungs.
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to wildtype lungs. This observation indicates that absence of Id1 function in lung 
endothelial cells can lead to increased immune cell recruitment.  
 
Discussion 
 
     Structural and functional alterations of the pulmonary endothelium are 
among the characteristic features of ALI pathogenesis (Groeneveld, 2002). The 
finding that Id1 is upregulated in pulmonary endothelial cells in different lung injury 
models suggests that Id1 may function as an important component in maintaining 
adult lung endothelial homeostasis. It appears that when endothelial cells are 
injured, by DNA-damaging chemicals or cytokines produced during systemic 
inflammation, Id1 expression is activated. The upstream signals that trigger Id1 
upregulation in these different lung injury models, however, remain to be 
investigated. One might speculate that a common stress-response signal may be 
activated to induce Id1 when the endothelial barrier is compromised. It also 
remains possible that different upstream signals may be involved in Id1 
upregulation in different types of ALI. 
Our finding that CLP-treated Id1-/- lungs showed increased vascular 
permeability compared to wildtype controls suggests that Id1 may play a critical 
role in maintaining endothelial integrity and function. In addition, immunostaining 
of neutrophil marker MPO revealed that the degree of inflammation, as 
demonstrated by increased neutrophil infiltration, is also elevated in CLP-injured 
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Fig 4.3 Loss of Id1 function in CLP-treated lungs results in 
increased neutrophil accumulation/inflammation. 
A. Representative photographs showing MMP2 
immunohistochemistry of lung sections from wildtype and Id1-
/- lungs with 19G CLP treatment for 8 hours. Sections were 
counterstained with hematoxylin to highlight nuclei. 
Magnification 400x. B. Neutrophil counting of wildtype and Id1-
/- sections from lungs with 19G CLP treatment for indicated 
hours. Results are obtained from 10 non-overlapping 400x 
fields of each group and shown as the number of MPO-
positive cells per field. Asterisk denote a significant difference 
(p<0.05) between wildtype and Id1-/- lungs.
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Id1-/- lungs. However, it remains to be seen whether the influence of Id1 protein 
function in pulmonary inflammation is direct or indirect. Redox (cellular reduction 
and oxidation state) balance is recognized as a key component in maintaining 
proper lung microvascular permeability and junctional integrity (Zhao et al., 2001). 
Following initial exposure to an inflammatory stimulus, injured endothelial cells 
produce reactive oxygen and nitrogen species (ROS and RNS, respectively) due 
to increased oxidant burden (Orfanos et al., 2004). Oxidative stress and ROS 
production mainly contribute to endothelial cell injury and death. Increase in the 
number of damaged endothelial cells due to oxidant-induced injury in turn can 
lead to the expression of damage-responsive proteins such as E-selectin and 
ICAM, which further facilitate recruitment of immune cells like neutrophils (Albelda 
et al., 1994). We speculate that the role of Id1 in protecting endothelial cells 
against excessive apoptosis and endothelial damage could alleviate the signaling 
cascade that ultimately leads to an increased inflammatory response. It would be 
interesting to examine the requirement of Id1 in injury-response gene expression 
to elucidate the link between Id1 function and lung inflammation processes. 
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CHAPTER V 
 
 
 
THE FUNCTION OF ID1 DURING CHRONIC PHASE OF LUNG INJURY 
 
 
 
Introduction 
 
Idiopathic pulmonary fibrosis (IPF) is a progressive chronic lung disease of 
unknown etiology and characterized by an initial accumulation of inflammatory 
cells, epithelial and endothelial injury and apoptosis, fibroblast proliferation, 
myofibroblast accumulation and increased deposition of extracellular matrix 
proteins resulting in irreversible distortion of lung architecture (Kuhn et al., 1989; 
Phan, 2002; Phan, 2003; Selman et al., 2001; Tomasek et al., 2002; Zhang et al., 
1994). Fibrotic lung diseases can be caused by a multitude of factors resulting in 
complex heterogeneous pathological conditions, and they contribute to the 
chronic events after acute lung injury (Matthay and Zimmerman, 2005). Our 
findings that Id1 expression is induced in adult mouse lung endothelial cells upon 
bleomycin exposure and that abrogating Id1 function results in increased vascular 
permeability and endothelial cell death in lung microvessels implicate a 
cytoprotective role of Id1 in the pulmonary endothelium.  In this chapter, we will 
emphasize the critical role of the lung endothelium, which has been implicated but 
not rigorously studied, in lung fibrogenesis. In addition, our proposed studies 
implicate a critical function of Id1 protein in the lung during the fibrotic process.  
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Experimental Procedures 
Mice and bleomycin treatment  
Id1 null mice (Id1-/-) (gift of Dr. Robert Benezra) and Tie1-Cre mice 
(Gustafsson et al., 2001) were bred in the C57BL/6J background and 
ShhCre-ZEG mice (Li et al., 2006) were bred in the C57BL/6J;129 background. 
For the Id1 time-course study, C57BL/6J mice (8-10 week old) were purchased 
from the Jackson Laboratory. Mice were treated with either saline or bleomycin 
(0.08U) by intratracheal injection in a total volume of 50ul saline (Lawson et al., 
2005b). The experimental protocol was reviewed and approved by the 
Institutional Animal Care and Utilization Committee at Vanderbilt University. 
 
Immunohistochemistry 
Lungs were perfused, inflated, excised, and fixed in 4% paraformaldehyde at 4oC 
overnight. Subsequently, lungs were embedded in paraffin blocks and 5 um 
sections were collected and processed for immunolabeling. Antibody against 
Smooth muscle alpha-actin (SMA, Sigma Chemical) was used for immunostaining. 
For regular immunolabeling, slides were antigen-retrieved using citrate buffer 
(pH6.0) and incubated at 4oC overnight with primary antibody. Regular 
Alexa-conjugated secondary antibodies or HRP-conjugated secondary antibodies 
(Jackson ImmunoResearch) and HRP detection kit (Labvision) were used for 
signal visualization.  
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Western blotting  
Left lungs of bleomycin-treated wildtype and Id1-/- mice were harvested 
and homogenized in RIPA lysis buffer at pH7.4. Protein lysates of 100ug each 
were resolved on SDS-polyacrylamide gels (Bio-Rad). Primary antibody against 
Smooth muscle alpha-actin (SMA, Sigma Chemical) was used for detection. 
Equal loading of protein samples was monitored by and normalized to the level of 
α-tubulin (Calbiochem-EMD Biosciences). Blots were analyzed using 
QuantityOne software (Bio-Rad). 
 
Histology and pathology scoring 
Lungs were perfused, inflated, excised, and fixed in 4% paraformaldehyde 
at 4oC overnight. Subsequently, lungs were embedded in paraffin blocks and 5 
um sections were collected and processed for H&E staining. Slides of lung tissue 
were randomized and evaluated on ten sequential, non-overlapping fields 
(magnification, 30X) of lung parenchyma for each specimen. Evaluation of 
parenchymal distortion on H&E-stained lung sections was done by Dr. Vasiliy 
Polosukhin, a pathologist in the Department of Allergy, Pulmonary and Critical 
Care Medicine at Vanderbilt University, blinded to the genotype and treatment 
group, using a 0 to 4 point scale, with a score of 0, normal architecture; 1, 
increased thickness of up to 50% of interalveolar septa; 2, thickening of >50% of 
interalveolar septa without formation of fibrotic foci; 3, thickening of the 
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interalveolar septa with formation of isolated fibrotic foci; and 4, formation of 
multiple fibrotic foci with total or subtotal distortion of parenchymal architecture 
(Lawson et al., 2005a).  
 
Hydroxyproline assay and Trichrome staining  
The left lungs of wildtype and Id1-/- mice, harvested at 2 weeks after 
bleomycin, were analyzed for hydroxyproline content as previously described 
(Reddy and Enwemeka, 1996). Briefly, the left lung lobes were weighed and 
homogenized in distilled water. The samples were mixed well and digested with 2N 
sodium hydroxide in a total volume of 100ul at 120oC for 20min. After digestion, 
900ul of chloramine T (1.27g chloramine T, 20 ml of 50% n-propanol and 
citrate-acetate buffer in 100ml) was added to each sample, mixed, and left at room 
temperature for 25 min. Then 1 ml of Ehrlich’s solution (15g of 
4-dimethylaminobenzaldehyde in 100ml n-propanol and 70% perchloric acid at a 
volume ratio of 2:1) was added to each sample, mixed and incubated for 20 min at 
65°C. Samples were cooled for 10 min and then read at 550 nm on a 
spectrophotometer. Concentrations were calculated against a hydroxyproline 
standard curve. Trichrome staining of lung sections for collagen content was 
performed by the Vanderbilt Immunohistochemistry Core Laboratory.  
Statistics 
To assess differences among groups, statistical analyses were performed 
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using a one-way analysis of variance (ANOVA) with Microsoft Excel (Microsoft 
Corporation) and significance accepted at p<0.05. Results are presented as mean 
+/- SEM. 
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Results 
Id1-/- mice display increased lung fibrogenesis during chronic phase of 
bleomycin-induced lung injury 
Since endothelial injury and the resulting increase in vascular permeability 
are often considered a pathological trigger of pulmonary fibrosis (Brown et al., 
1989; Magro et al., 2006; Renzoni et al., 2003; Takabatake et al., 2005), we 
examined the susceptibility of Id1-/- lungs to bleomycin-induced fibrogenesis. First, 
we performed morphological analysis of Id1-/- and wildtype lungs by histological 
staining with hematoxylin and eosin (H&E) of lung sections harvested at two 
weeks after bleomycin instillation to assess the alveolar architecture. As indicated 
in Figure 5.1-A, Id1-/- lungs showed more parenchymal distortion and fibrotic foci 
compared to bleomycin-treated wildtype lungs. For semi-quantitative analysis of 
lung fibrosis, H&E-stained sections were evaluated by a pathologist (see Methods) 
blinded to the genotypes and treatment groups. As shown in Figure 5.1B, Id1-/- 
lungs displayed a higher parenchymal distortion, approximately 35% increase, 
compared with wildtype (N=5).  
 
Id1-/- lungs display more collagen accumulation in bleomycin-induced 
fibrogenesis 
One of the hallmarks of lung fibrosis is the accumulation of collagen that is 
secreted by the large fibroblast population within foci. By Trichrome staining, 
which specifically highlights extracellular collagen, we observed significantly more 
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Fig 5.1 Id1-/- lungs are more susceptible to bleomycin-induced 
fibrogenesis.  
A. Hematoxylin and eosin staining of lung sections to show 
architectural changes. Representative photographs showing foci 
formation in wildtype and Id1-/- lungs at 2 weeks post-bleomycin. 
Magnification 40x.  B. Increase in the index of architectural 
distortion in Id1-/- lungs compared to wildtype lungs after bleomycin 
challenge. Double asterisks denote a significant difference (p<0.01) 
between wildtype and Id1-/- lungs at 2 weeks post-bleomycin (n=5 
for each group). 
92
collagen accumulation in the fibrotic foci of Id1-/- lungs at 2 weeks post-bleomycin 
compared with wildtype (Fig. 5.2-A, collagen as bright blue). In agreement with 
the Trichrome staining result, we detected about 90% increase in collagen 
deposition in Id1-/- lungs compared with wildtype, two weeks post-bleomycin as 
measured by hydroxyproline content assay (N=4, Fig. 5.2-B).  
 
Id1-/- lungs display more myofibroblast differentiation in bleomycin-induced 
fibrogenesis 
Consistent with elevated collagen secretion, Id1-/- lungs also showed 
significant increase in the population of myofibroblasts within developing foci as 
revealed by Smooth muscle α-actin (SMA) immunolabeling (Fig. 5.3-A) of lungs 
two weeks post-bleomycin treatment. Accordingly, Western blotting of Id1-/- lung 
homogenates revealed increased levels of SMA compared with wildtype. (Fig. 
5.3-B). Taken together, we demonstrate that Id1-/- mutant lungs are more 
susceptible to bleomycin-induced fibrogenesis as evidenced by increased lung 
parenchymal distortion, elevated collagen and hydroxyproline content and larger 
myofibroblast cell population. These findings implicate a critical role of the 
pulmonary endothelium in mediating the fibrotic response upon lung injury and 
underscore Id1 as a key molecular participant.  
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Fig 5.2 Id1-/- lungs display more ECM accumulation in 
bleomycin-induced fibrogenesis. 
A. Trichrome staining showing increased collagen deposition in 
lungs of Id1-/- mice after bleomycin challenge. Representative 
photographs reveal increased collagen accumulation (blue) in Id1-
/- lungs compared to wildtype at 2 weeks post-bleomycin. 
Magnification 40x. B. Quantification of collagen deposition in 
lungs of wildtype and Id1-/- mice after bleomycin challenge by 
hydroxyproline assay. Asterisks denote a significant difference 
(p<0.05) between wildtype and Id1-/- lungs at 2 weeks post-
bleomycin (n=4 for each group).
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Fig 5.3 Id1-/- lungs display more myofibroblast 
differentiation in bleomycin-induced fibrogenesis.
A. Immunostaining of wildtype and Id1-/- lungs with antibodies 
specific for a-smooth muscle actin (SMA). Representative 
sections are shown for lungs at 2 weeks post-bleomycin or saline. 
Sections were counterstained with hematoxylin to highlight all 
nuclei. Note elevated expression of SMA in fibrotic foci of Id1-/-
lungs compared with wildtype. Magnification 40x. B. Western 
blotting showing expression level of SMA in wildtype and Id1-/-
lungs at 2 weeks post-bleomycin or saline. Values represent the 
relative fold change of SMA protein level normalized to the 
density of α-tubulin bands.
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Discussion 
Numerous reports using animal models indicate that antioxidants, drugs, 
biological factors or specific genetic alterations can provide protection against 
lung injury suggesting that the pathogenesis of ALI involves complex cellular and 
molecular mechanisms (Aoki et al., 2005; Brewer et al., 2003; El-Medany et al., 
2005; Hamaguchi et al., 2002; Manoury et al., 2005; Murakami et al., 2004; 
Otsuka et al., 2004; Ozyurt et al., 2004; Serrano-Mollar et al., 2003; Sogut et al., 
2004; Zhao et al., 2002; Zuo et al., 2002). In this study, we have uncovered a 
critical function of Id1 in the lung endothelium upon bleomycin-induced lung injury 
that results in fibrosis. We show significant upregulation of Id1 protein expression 
during the first week after exposure to bleomycin and expression is maintained for 
several weeks. Compared with wildtype, lungs lacking Id1 function displayed 
increased bleomycin-induced vascular permeability and endothelial cell death and 
more pronounced lung architectural distortion and fibrosis that are associated with 
significant increase in fibroblast and myofibroblast populations and collagen 
deposition.  
Together with the results obtained in Chapter 3, our findings support a 
critical role of Id1 as a protective molecule induced in the lung endothelium upon 
injury and underscore a key role of the lung endothelium during fibrogenesis. 
Injury caused by bleomycin results in extensive apoptosis in the endothelium and 
other lung cell types (Hamada et al., 2005). Pulmonary endothelial cells respond to 
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tissue damage by upregulating Id1 expression through unknown stress response 
signals. I found that upregulation of Id1 in endothelial cells activates the MEK/ERK 
pathway and elevates expression of anti-apoptotic protein Bcl-2 (Fig 3.11). It is 
reasonable to suggest that increased Bcl-2 protein level can reduce the extent of 
endothelial apoptosis. Acute lung injury often results in pulmonary fibrosis in the 
chronic phase, which appears to be attenuated indirectly by Id1 function due to 
decreased endothelial cell death (Fig5.4). The lung microvasculature is intimately 
associated with the alveolar epithelium for efficient blood-gas exchange and it has 
been suggested that functional defects of microvessels may play a role in the 
pathogenesis of lung fibrosis. Pulmonary microvascular lesions and increased 
vascular permeability have been linked to the pathogenesis of pulmonary fibrosis 
therefore limiting endothelial cell injury and cell death may alleviate fibrogenesis 
(Brown et al., 1989; Kaplan et al., 1992; Magro et al., 2003; Magro et al., 2006; 
Peterson et al., 1992; Renzoni et al., 2003; Slosman et al., 1989; Takabatake et 
al., 2005; Wang et al., 1992). Several other studies have also implicated a role of 
the microvasculature in lung fibrosis (Azuma et al., 2000; Burdick et al., 2005; 
Drab et al., 2001; Fichtner et al., 2004; Kasper et al., 1996; Kawanami et al., 1995; 
Piguet and Vesin, 1994; Ward et al., 1989). Conceivably, increased microvascular 
damage in Id1-/- lungs may lead to increased extravasation of plasma that could 
promote fibroblast proliferation. In addition, stimulated/injured endothelial cells 
can also secrete fibrogenic molecules that may affect fibroblast migration and 
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proliferation (Calabrese et al., 2005). Our findings indicate that Id1 plays a critical 
role in promoting endothelial survival after bleomycin-induced injury and further 
suggest a role of the lung endothelium in lung fibrogenesis.  
Although upregulation of Id1 protein is predominantly found in lung 
endothelial cells, the potential roles of Id1 in other cells types contributing to the 
pathogenesis of lung injury and fibrogenesis need to be further investigated 
(Fig5.4). For example, a previous report by Chambers et. al., (Chambers et al., 
2003) and our study showing Id1 and SMA double-immunolabeling indicate that 
some Id1-expressing cells display fibroblastic features. With new discoveries of 
fibroblast-specific molecular markers that label all the fibroblast population within 
the lung, it will be possible to investigate the role of Id1 in fibroblast proliferation 
and differentiation during fibrogenesis.  In addition, Id1 has been shown to have 
moderate expression in a sub-group of immune cells such as macrophages and 
granulocytes (Leeanansaksiri et al., 2005). Therefore, Id1 may also be involved in 
the inflammatory response of lungs upon injury that results in fibrogenesis. 
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Fig 5.4 Schematic representation of Id1 function in the lung 
endothelium in acute lung injury.
Injury caused by bleomycin results in extensive endothelial 
apoptosis. The lung responds to tissue damage by upregulating Id1 
expression in endothelial cells (and other cell types). Upregulation 
of Id1 in endothelial cells activates the MEK/ERK pathway and 
elevate expression of anti-apoptotic protein Bcl-2. Increased Bcl-2 
protein level reduces the extent of endothelial cell apoptosis thus 
alleviating endothelial damage. Acute lung injury often results in 
pulmonary fibrosis in the chronic phase, which may be attenuated
by Id1 function.
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CHAPTER VI 
 
 
 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
 
 
 
Since the first Id protein was discovered more than a decade ago, the Id 
family of transcription inhibitors has attracted the attention of investigators from 
diverse research fields. Numerous studies focused on Id family proteins revealed 
that their functions encompass an extremely wide range of biological processes 
including myogenesis (Katagiri et al., 2002), angiogenesis (Benezra et al., 2001), 
neurogenesis (Lyden et al., 1999), hematopoietic lineage commitment (Benezra 
et al., 2001; Leeanansaksiri et al., 2005; Norton, 2000), spermatogenesis 
(Chaudhary and Skinner, 1999; Sablitzky et al., 1998), proliferation (Lasorella et 
al., 2001; Yokota and Mori, 2002; Zebedee and Hara, 2001) and apoptosis (Wong 
et al., 2004).  
In this project, we investigated the roles of Id genes in modulating 
pulmonary endothelial cell function during lung development and in adult acute 
lung injury. We uncover the importance of Id1 gene function in attenuating 
endothelial cell apoptosis and dysfunction in the adult lung upon insult by 
intratracheal instillation of bleomycin. We also provide data to support the 
potential roles of Id1 and Id3 in endothelial morphogenesis during embryonic lung 
development. We utilized the Id1 and Id3 single or double knockout mice as they 
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are ideal genetic tools for studying the functions of theses genes.  
The finding that Id1 expression is significantly upregulated in adult mouse 
lung endothelial cells upon bleomycin-induced injury and abrogating Id1 function 
results in increased vascular permeability and endothelial apoptosis, hence 
contributing to increased lung injury, underscores the importance of Id1 function in 
maintaining endothelial survival and homeostasis in response to stress. This 
study also emphasizes the critical role of the lung endothelium in both acute and 
chronic phases of lung injury. However, Id1 also functions in other cell types such 
as endothelial progenitor cells and immune cells under conditions of cellular 
stress  (Benezra et al., 2001; Leeanansaksiri et al., 2005; Lyden et al., 2001; 
Norton, 2000). In this chapter, I will contemplate the other possible functions of 
Id1 in the pathogenesis of acute lung injury and fibrosis. I will also discuss 
potential upstream and downstream signaling pathways regulating Id protein 
expression in the context of development and disease.   
 
The role of Id proteins in lung angiogenesis and endothelial survival 
I have carried out several studies to investigate the contribution of Id 
protein functions in endothelial cell growth, differentiation and injury response. 
These studies are in agreement with published reports that Id proteins are key 
regulators of endothelial function. In my study using Id1-/-Id3-/- double knockout 
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embryonic lungs, I showed that Id1 and Id3 may promote angiogenesis and they 
may be required for maintaining MMP-2 expression in endothelial cells.  
Recent studies suggest that Notch signaling may play an essential role in 
dictating cell fate determination in the lung, particularly during vascular 
development (Iso et al., 2003a). Notch-1 and its ligand Jagged-1 are specifically 
expressed in endothelial cells of pulmonary vessels, a pattern not seen in other 
organs (Taichman et al., 2002). Humans with Alagille syndrome (AGS), which is 
caused by mutation of Jagged-1, display major abnormalities in pulmonary 
arteries (Oda et al., 1997). Herp3, a primary effector of Notch signaling, also 
shows strong expression level in pulmonary endothelial cells (Chin et al., 2000). 
These findings support the notion that Notch signaling is involved in pulmonary 
vascular development. Interestingly, the Herp proteins belong to the bHLH family 
of transcription factors. Thus, I speculate that Id1 and/or Id3 may physically 
interaction with Herp in regulating Notch signaling activity. Ets transcription 
factors also comprise a group of interaction partners for Id proteins (Yates et al., 
1999). The Ets-domain transcription factor Net is highly expressed in the lung 
mesenchyme during embryogenesis (Ayadi et al., 2001a). Interestingly, mice 
deficient in Net function exhibit severe vascular defects in the embryonic lung 
(Ayadi et al., 2001b), suggesting a potential role of Net during lung angiogenesis. 
Therefore, Net may serve as another potential candidate Id target in the 
embryonic lung endothelial cells.  
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Although the relationship between Id proteins and apoptosis in cancer cells 
has been expansively studied (Wong et al., 2004), little information is available 
regarding the relationship between Id1 and apoptosis of endothelial cell. In our 
study, we demonstrated that Id1-/- lung endothelial cells, when challenged with 
bleomycin, display increased apoptosis in vivo and in vitro. Our results also 
suggest that Id1 may exert its protective function by maintaining Bcl-2 expression, 
possibly through activation of Ras/MEK pathway. However, our preliminary 
observation suggests that other mechanisms might also contribute to the 
protection against endothelial cell death by Id1. We have found that the transcript 
and protein levels of p21, a cyclin-dependent kinase (CDK) inhibitor, were higher 
in bleomycin-exposed Id1-/- lung endothelium compared with wildtype. This 
finding correlates with increased p21 protein level observed in Id1-/- LMVECs 
challenged with bleomycin (Fig. 6.1). This result is consistent with several 
previous studies implicating the upregulation of p21 in induction of endothelial 
apoptosis (Kurosawa et al., 2002; Lin et al., 2002; Pendergraft et al., 2004; Yang 
et al., 1996). Our finding supports a role of p21 as another downstream effector of 
Id1, which can modulate the transcriptional repression of the p21 gene promoter 
containing E-box binding sequences (Prabhu et al., 1997). Although some reports 
suggest that p21 favors inhibition of apoptosis under certain conditions (Gartel 
and Tyner, 2002), our findings indicate that repression of p21 by Id1 may be one 
mechanism by which Id1 suppresses apoptosis. Another possible target of Id1 is 
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Fig 6.1 Bleomycin-injured Id1-/- lungs display increased
endothelial barrier dysfunction, elevated endothelial apoptosis
and p21CIP/WAF-1 level
A. Western blotting of FACS-sorted endothelial (GFP+) and non-
endothelial cells (GFP-) from wildtype or Id1-/- lungs collected at 1
week post-bleomycin or saline. Values showing relative fold change of
p21 protein level normalized to the density of α-tubulin bands. Note
that p21 expression was further increased in the endothelial population
in the absence of Id1 function (lane 8 versus lane 4, arrows). B. Real
Time PCR analysis using total RNA extracted from FACS-sorted
endothelial (GFP+) and non-endothelial cells (GFP-) of wildtype or Id1-
/- lungs collected at 1 week post-bleomycin or saline (N=2). Results
show the average fold change of p21 mRNA level from two
independent experiments. C. Western blotting of triplicate cell lysates
from wildtype or Id1-/- primary LMVECs treated with saline or 250ng/ml
bleomycin for 6 hours. Values showing relative fold change in p21
protein level normalized to the density of a-tubulin bands. Note that p21
level is significantly increased in  LMVECs in the absence of Id1
function (lanes 4, 5, 6 versus lanes 1, 2, 3).
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E2F-1, a basic HLH domain-containing transcription factor that is essential to 
mediate DNA damage-induced apoptosis (Norbury and Zhivotovsky, 2004). Since 
a prominent feature of Id1 function is to inhibit the transcriptional activities of basic 
HLH proteins, Id1 might prevent cell death by binding to E2F-1 or its dimerization 
partners thus disrupting E2F-1 function.  
 
The functions of Id1 in other lung cell types 
Besides the processes of vascular development presented in Chapter 2, Id 
proteins are also involved in the development of the nervous system and the 
immune system, as revealed by analysis of Id1 and Id3 knockout mice (Lyden et 
al., 1999). Therefore, in order to expand our knowledge on Id proteins in lung 
development, efforts should be geared toward investigating the requirement of Id 
proteins in the generation and/or maintenance of other lung cell types during 
development. Neural network development in the embryonic lung progresses in 
parallel with endothelial morphogenesis (Tollet et al., 2001). I found elevated Id1 
and Id3 expression in the lung mesenchyme where neurogenesis occurs, 
suggesting that Id functions may be required for the development of the nervous 
system in the lung, similar to the embryonic brain (Fig 2.1). Examination of neural 
cell distributions in Id1-/-Id3-/- double knockout lungs using different neuronal 
markers may reveal the importance of Id proteins in neurogenesis during lung 
development. 
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The lung endothelium, when subjected to acute injury, undergoes 
extensive cell apoptosis, as revealed by our studies in Chapter 3. However, little 
or no proliferative activity was detected in resident lung endothelial cells of the 
injured lung. Therefore, I reason that in order for the lung tissue to survive the 
acute damage, which can potentially lead to respiratory failure, the lung 
endothelium must possess a mechanism to replenish depleted endothelial cells 
from sources outside of the lung. Recent studies have shown that repair of lung 
endothelium can be achieved by recruitment of blood-borne endothelial progenitor 
cells (EPCs) which are unique types of cells with angiogenic properties that home 
to sites of endothelial injury (Asahara et al., 1999; Burnham et al., 2005; Chinoy et 
al., 2005; Khakoo and Finkel, 2005; Takahashi et al., 1999; Yamada et al., 2005). 
The potential role of circulating EPCs in acute lung injury and pulmonary fibrosis 
has opened up a new paradigm for investigative research in acute lung injury and 
fibrotic lung diseases. However, the mechanism of EPC cell recruitment remains 
poorly understood. I contemplate the possibility that increased endothelial injury in 
Id1-/- lung may require enhanced recruitment of circulating EPCs for vascular 
repair, however, lack of Id1 function in EPCs may also affect the repair 
mechanism (Lyden et al., 2001). Recently, by using a GFP-marked EPC 
engraftment procedure in mice followed by treatment with bleomycin, it was 
demonstrated that EPCs derived from outside of the lung do contribute to 
pulmonary endothelial repair (Asahara et al., 1999). Using a similar approach to 
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introduce GFP-marked wildtype or Id1-/- EPCs into injured lungs, we may reveal 
novel functions of Id1 protein in endothelial progenitor cell recruitment during 
acute lung injury. 
Delineating the origins of effector fibroblast populations in the lung will 
provide important insights into the pathogenesis of lung fibrosis. Currently, two 
sources for lung fibroblasts have been shown to significantly contribute to lung 
fibrosis: circulating fibrocytes (Garantziotis et al., 2004) and proliferating resident 
fibroblasts. Although the lung alveolar epithelial cell can transdifferentiate into 
fibroblast, its relative contribution to lung fibrosis remains to be determined (Kasai 
et al., 2005; Willis et al., 2005). As shown in previous studies, endothelial cells 
have the capacity to differentiate into smooth muscle cells (Arciniegas et al., 1992; 
Frid et al., 2004; Frid et al., 2002; Ishisaki et al., 2003), suggesting that endothelial 
cells may be another potential source of lung fibroblast contributing to 
fibrogenesis. In light of the role of Id1 as an inhibitor of myofibroblast 
differentiation, I contemplate the possibility that endothelial expression of Id1 
upon injury may also help prevent endothelial-to-fibroblast transdifferentiation. 
Using lung microvascular endothelial cells (LMVEC) isolated from wildtype or 
Id1-/- mice, we can examine the potential of Id1-/- endothelial cells to differentiate 
into α-SMA-positive cells upon TGF-β stimulation. Furthermore, using 
Tie1Cre-GFP transgenic mouse line that faithfully marks cells of endothelial origin 
(Gustafsson et al., 2001), we can assess the extent of endothelial-to-fibroblast 
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transdifferention in intact wildtype and Id1-/- lungs under pathological conditions 
and the contribution of Id1 in this process. 
Id1 has been shown to be moderately expressed in a subgroup of immune 
cells such as the macrophages and granulocytes (Leeanansaksiri et al., 2005). An 
association between loss of Id function and deregulated inflammatory cell 
differentiation has also been reported (Benezra et al., 2001; Leeanansaksiri et al., 
2005; Norton, 2000) Therefore, although our current studies focus on the role of 
Id1 protein in endothelial cell integrity and survival, the possibility remains that 
altered inflammatory response in challenged Id1-/- mice, can contribute, at least in 
part, to increased lung injury and fibrosis. In order to address this question, it is 
possible to analyze the population of inflammatory cells in Id1-/- lung alveolar 
space and interstitium compared with wildtype at 3, 7,14 and 21 days after 
bleomycin instillation. Differential cell counts in the fraction of eosinophils, 
neutrophils and macrophage/monocytes will reveal possible contribution of Id1 
function in immune response processes during bleomycin-induced injury. 
 
Potential upstream signaling pathways regulating expression of Id proteins  
The upstream signaling pathways that regulate Id gene expression during 
lung development and, in particular, in disease progression remain largely 
unknown. However, considerable work has been focused on the signals 
controlling expression of the Id genes in diverse cell types in vitro. Although the 
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expression of Id genes are likely stimulated by various factors, Bone 
morphogenetic proteins (Bmps) play a major role in regulating Id expression 
(Miyazono and Miyazawa, 2002). Bmps can induce the expression of Id1, Id2 and 
Id3 in a Smad-dependent manner in several established cell lines (Hollnagel et al., 
1999; Miyazono and Miyazawa, 2002; Ogata et al., 1993). Analysis of the Id1 
promoter revealed that it contains two Bmp-responsive sites, one of which 
contains CGCC sequence elements flanked by CAGC motifs and the other one 
harbors two Smad-binding elements (SBEs). Activation of the Id1 promoter upon 
treatment with Bmps demonstrated that Id1 is a direct target of Bmp signaling 
(Korchynskyi and ten Dijke, 2002).  During embryonic lung development, Bmp4, 
a member of the Bmp protein family that is most extensively studied in lung 
morphogenesis, is expressed in the distal epithelium at high level and subjacent 
mesenchyme at lower level (Bellusci et al., 1996). These Bmp4 signaling domains 
overlap extensively with Id1 and Id3 expression in the mesenchyme and Id2 
expression in the epithelium. In addition, our Bmp4-bead implantation experiment 
also revealed that addition of Bmp4 protein in embryonic lung mesenchyme 
significantly upregulates Id1 and Id3 expression (Fig. 6.2). Taken together, these 
lines of evidence indicate that the Id proteins are likely under direct regulation by 
Bmp proteins in the embryonic lung to transduce Bmp-regulated biological effects. 
Although direct correlation between Bmp signaling and lung injury and 
fibrogenesis has not been established, related studies suggest that Bmps may be 
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Fig 6.2 Ectopic Bmp4 signaling in distal lung mesenchyme induces
Id1 and Id3 gene expression.
Human recombinant BMP4 protein soaked bead (arrows) or BSA soaked
bead (arrowheads) were implanted into mesenchymal layers at similar
locations of E11.5 WT lungs. Lungs were collected 24 hours after culture
and analyzed for Id1 (A) and Id3 (B) expression by whole-mount in situ
hybridization.
A B
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actively engaged in the pathogenesis of fibrosing diseases. Bmp7 signaling has 
been implicated in the attenuation of kidney fibrosis by restoring and maintaining 
renal epithelial phenotype via down-modulation of epithelial-to-mesenchymal 
transition induced by TGF-β1 (Morrissey et al., 2002; Zeisberg et al., 2003). 
Therefore Bmp-mediated signaling may be a critical component pathway involved 
in lung injury and fibrosis. Vascular endothelial growth factor (VEGF) has also 
been shown to induce Id1 and Id3 in human umbilical vascular endothelial cells 
(HUVECs) (Sakurai et al., 2004) and hematopoietic cells (Lyden et al., 2001). 
Since VEGF is renowned for its role in endothelial survival and its involvement in 
endothelial injury (Fehrenbach et al., 1999; Gupta et al., 1999; Hamada et al., 
2005; Koyama et al., 2002; Meyer et al., 2000), VEGF may be another potential 
Id1 inducer. Another example is fluvastatin, a 3-hydroxy-3-methylglutaryl 
coenzyme A (HMG-CoA) reductase inhibitor with pleiotropic effects on cellular 
metabolism. Several reports indicate that fluvastatin can act as antioxidant and an 
effective inhibitor against lipid peroxidation (Suzumura et al., 2001; Suzumura et 
al., 1999; Yamamoto et al., 1998; Yamamoto et al., 2001). Interestingly, Id1 has 
been shown to be upregulated by fluvastatin in human dermal microvascular 
endothelial cells (Pammer et al., 2004). However, it remains to be determined if 
fluvastatin can upregulate Id1 in the lung endothelium and since this drug is known 
for its pleitropic effects, its cell-specific mechanism of action should be carefully 
examined.  
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Wildtype mice display endothelial damage and fibrosis, albeit less severe than 
Id1-/- mice, suggesting that increase in Id1 level above baseline in 
bleomycin-challenged wildtype lungs is not sufficient to provide full protection. 
This point raises an important issue as to whether there exists a competition or 
balance in vivo between Id1-inducing and Id1-repressing mechanisms upon lung 
injury. It is possible that the level of Id1 upregulation we observed upon challenge 
does not reflect maximally induced Id1 levels due to coexisting Id1-repressing 
signals. While the Id1-inducing and protective mechanism promotes the 
maintenance of endothelial cell function, antagonistically, the persistence of 
pro-inflammatory cytokines may downregulate Id1 expression, thus promoting 
endothelial dysfunction, vascular leakage and fibrosis. Signaling mediated by 
TGF-β1 and TNF-α are known to play key roles in many types of lung diseases 
including bleomycin-induced pneumopathy in animal models (Bartram and Speer, 
2004; Cutroneo and Phan, 2003; Nakao et al., 1999; Pittet et al., 2001; Santana et 
al., 1995; Wang et al., 2002; Zhao et al., 2002). TGF-β activated Smad2/3 and 
stress-induced signalings are believed to mediate lung fibrogenesis in 
bleomycin-treated animals (Phan and Kunkel, 1992; Wang et al., 2002; Zhao et 
al., 2002). Interestingly, TGF-β1 can exert long-term repression of Id1 expression 
in a number of cell types including endothelial cells, suggesting that TGF-β can 
potentially contribute to the downregulation of Id1 expression during lung fibrosis.  
TNF-α signaling has also been implicated in the regulation of Id expression 
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in astrocytes during inflammatory injury of the central nervous system (Goumans 
et al., 2002; Kang et al., 2003; Tzeng et al., 1999). One of the key downstream 
components of TNF-α is mediated by p38 MAPK, which has been shown to 
directly downregulate Id1 expression in epithelial cells (Kang et al., 2003). 
Activation of p38 MAPK has been demonstrated in various disease models 
involving vascular injury and pulmonary fibrosis and p38 MAPK inhibitors can 
reduce the severity of the disease condition (Ju et al., 2002; Mackay and 
Mochly-Rosen, 1999; Matsuoka et al., 2002). p38 MAPK activation in endothelial 
cells of IPF patients was found to occur at an intermediate stage of fibrosis 
(Yoshida et al., 2002). Activation of p38 MAPK has been reported in human 
pulmonary microvascular endothelial cells (HMVEC) upon exposure to bleomycin 
indicating a key role of stress-induced p38 MAPK in lung microvascular 
endothelium (Fichtner et al., 2004). p38 MAPK can mediate TNF-α-induced 
microtubule rearrangements and increase in lung vascular permeability and 
endothelial barrier dysfunction and SB203580, a p38 MAPK inhibitor, can rescue 
TNF-α-induced cellular changes (Goldblum et al., 1993; Goldblum et al., 1994; 
Petrache et al., 2003). p38 MAPK has also been implicated in lung endothelial 
barrier dysfunction by modulating microtubule disassembly (Birukova et al., 2005). 
These observations indicate a key role of p38 MAPK in lung endothelium in 
response to stress. Speculatively, one consequence of TNFα signaling and p38 
MAPK activation in the course of lung injury is the downregulation of Id1, which 
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Fig 6.3 TNF-alpha downregulates Id1 in endothelial cells in a p38-
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A. Western blot analysis showed that Bmp4-induced Id1 expression in
LMVEC cells is rapidly repressed to baseline by TNF-alpha. This
downregulation of Id1 is largely mediated by p38-MAPK, as its specific
inhibitor SB203580 can reverse the effect of TNF-alpha. B. Densitometric
measurements of Id1 bands were performed and normalized to the
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must be counteracted and counterbalanced by inducers of Id1 expression. My 
preliminary studies indicating that TNF-α mediated signaling can downregulate 
Id1 expression in cultured LMVECs in a p38 MAPK-dependent manner (Fig. 6.3) 
set the stage for investigating the role of p38 MAPK signaling in regulating Id1 
expression in vivo. Future studies using a combination of biochemical, molecular 
and genetic approaches will advance our understanding of the regulatory 
mechanisms underlying Id1 expression and function in the pathogenesis of acute 
lung injury and fibrosis. 
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